<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">90648</article-id>
<article-id pub-id-type="doi">10.7554/eLife.90648</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90648.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Structural Biology and Molecular Biophysics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>CryoEM structures of the human CLC-2 voltage gated chloride channel reveal a ball and chain gating mechanism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Mengyuan</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neelands</surname>
<given-names>Torben</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Powers</surname>
<given-names>Alexander S.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>Steven D.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pintilie</surname>
<given-names>Grigore</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du Bois</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dror</surname>
<given-names>Ron O.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chiu</surname>
<given-names>Wah</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Maduke</surname>
<given-names>Merritt</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Molecular and Cellular Physiology, Stanford University</institution>, Stanford, CA 94305</aff>
<aff id="a2"><label>2</label><institution>Department of Chemistry, Stanford University</institution>, Stanford, CA 94305</aff>
<aff id="a3"><label>3</label><institution>Department of Computer Science, Stanford University</institution>, Stanford, CA 94305</aff>
<aff id="a4"><label>4</label><institution>Department of Structural Biology, Stanford University</institution>, Stanford, CA 94305</aff>
<aff id="a5"><label>5</label><institution>Institute for Computational and Mathematical Engineering, Stanford University</institution>, Stanford, CA 94305</aff>
<aff id="a6"><label>6</label><institution>Division of CryoEM and Bioimaging, SSRL, SLAC National Accelerator Laboratory, Stanford University</institution>, Menlo Park 94025</aff>
<aff id="a7"><label>7</label><institution>Department of Bioengineering and Department of Microbiology and Immunology, Stanford University</institution>, Stanford, 94305</aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Stockbridge</surname>
<given-names>Randy B</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Michigan</institution>
</institution-wrap>
<city>Ann Arbor</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Swartz</surname>
<given-names>Kenton J</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>National Institute of Neurological Disorders and Stroke</institution>
</institution-wrap>
<city>Bethesda</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Dr. Merritt Maduke 279 Campus Drive West Stanford, CA 94035 Tel: 650-723-9075 Email: <email>maduke@stanford.edu</email></corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-09-21">
<day>21</day>
<month>09</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP90648</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-07-27">
<day>27</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-08-15">
<day>15</day>
<month>08</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.13.553136"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Xu et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xu et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-90648-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>CLC-2 is a voltage-gated chloride channel that contributes to electrical excitability and ion homeostasis in many different mammalian tissues and cell types. Among the nine mammalian CLC homologs, CLC-2 is uniquely activated by hyperpolarization, rather than depolarization, of the plasma membrane. The molecular basis for the divergence in polarity of voltage gating mechanisms among closely related CLC homologs has been a long-standing mystery, in part because few CLC channel structures are available, and those that exist exhibit high conformational similarity. Here, we report cryoEM structures of human CLC-2 at 2.46 – 2.76 Å, in the presence and absence of the potent and selective inhibitor AK-42. AK-42 binds within the extracellular entryway of the Cl<sup>−</sup>-permeation pathway, occupying a pocket previously proposed through computational docking studies. In the apo structure, we observed two distinct apo conformations of CLC-2 involving rotation of one of the cytoplasmic C-terminal domains (CTDs). In the absence of CTD rotation, an intracellular N-terminal 15-residue hairpin peptide nestles against the TM domain to physically occlude the Cl<sup>−</sup>-permeation pathway from the intracellular side. This peptide is highly conserved among species variants of CLC-2 but is not present in any other CLC homologs. Previous studies suggested that the N-terminal domain of CLC-2 influences channel properties via a “ball-and-chain” gating mechanism, but conflicting data cast doubt on such a mechanism, and thus the structure of the N-terminal domain and its interaction with the channel has been uncertain. Through electrophysiological studies of an N-terminal deletion mutant lacking the 15-residue hairpin peptide, we show that loss of this short sequence increases the magnitude and decreases the rectification of CLC-2 currents expressed in mammalian cells. Furthermore, we show that with repetitive hyperpolarization WT CLC-2 currents increase in resemblance to the hairpin-deleted CLC-2 currents. These functional results combined with our structural data support a model in which the N-terminal hairpin of CLC-2 stabilizes a closed state of the channel by blocking the cytoplasmic Cl<sup>−</sup>-permeation pathway.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>chloride channel</kwd>
<kwd>cryo-electron microscopy</kwd>
<kwd>electrophysiology</kwd>
</kwd-group>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Ion transport across the cell membrane establishes and exploits ion gradients to store energy and regulate electrical signaling. Ion transport is catalyzed by two classes of membrane proteins: ion channels and active transporters. The CLC “Chloride Channel” family encompasses both major ion-transport mechanisms: half of the CLC homologs are electrodiffusive chloride (Cl<sup>−</sup>) channels, and half are secondary active transporters that stoichiometrically exchange Cl<sup>−</sup> for protons (H<sup>+</sup>) (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). The occurrence of two mechanisms in one family suggests they operate by variations on a common theme (<xref ref-type="bibr" rid="c60">Miller, 2006</xref>), and experimental results revealed that CLC channels are “broken” transporters (<xref ref-type="bibr" rid="c56">Lisal and Maduke, 2008</xref>).</p>
<p>In both CLC channels and transporters, a conserved glutamate residue referred to as the “gating glutamate” (E<sub>gate</sub>) plays a central mechanistic role. High resolution CLC transporter structures show that this residue can adopt four different conformations (<xref ref-type="bibr" rid="c25">Dutzler et al., 2002</xref>; <xref ref-type="bibr" rid="c26">Dutzler et al., 2003</xref>; <xref ref-type="bibr" rid="c30">Feng et al., 2010</xref>; <xref ref-type="bibr" rid="c13">Chavan et al., 2020</xref>; <xref ref-type="bibr" rid="c85">Schrecker et al., 2020</xref>) (<bold><xref rid="fig1" ref-type="fig">Figure 1A</xref></bold>), which contribute to the Cl<sup>−</sup>/H<sup>+</sup> exchange mechanism (<xref ref-type="bibr" rid="c2">Accardi and Miller, 2004</xref>; <xref ref-type="bibr" rid="c31">Feng et al., 2012</xref>; <xref ref-type="bibr" rid="c13">Chavan et al., 2020</xref>; <xref ref-type="bibr" rid="c53">Leisle et al., 2020</xref>). Due to the small number of CLC channel structures relative to transporters, characterization of the central role for the E<sub>gate</sub> residue in CLC channels has primarily relied on extensive functional studies of channel gating rather than observed E<sub>gate</sub> side chain conformations (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). The first CLC channel structure reported was of bovine CLC-K (<xref ref-type="bibr" rid="c71">Park et al., 2017</xref>), a kidney-expressed homolog that is the lone CLC homolog lacking the E<sub>gate</sub> (<xref ref-type="bibr" rid="c50">Kieferle et al., 1994</xref>). The only other CLC channel structures reported prior to 2023 are of the human CLC-1: one of these cryoEM structures shows E<sub>gate</sub> in the “out” position (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>) while the other lacked density for E<sub>gate</sub> (<xref ref-type="bibr" rid="c95">Wang et al., 2019</xref>). The E<sub>gate</sub> “out” position was originally posited to be exclusive to the CLC channel homologs, as its positioning off to the side widens the Cl<sup>−</sup>-permeation pathway and, in CLC-1, results in a continuous pathway (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>). Such a continuous pathway precludes exchange coupling (<xref ref-type="bibr" rid="c46">Jardetzky, 1966</xref>; <xref ref-type="bibr" rid="c62">Miller, 2021</xref>). The open Cl<sup>−</sup>-permeation pathway in the CLC-1 structure is consistent with the known functional properties of CLC-1 in the absence of an applied transmembrane voltage. CLC-1 is a voltage-gated channel that is predominantly in the open state at zero mV (<xref ref-type="bibr" rid="c5">Altamura et al., 2020</xref>) (<bold><xref rid="fig1" ref-type="fig">Figure 1B</xref></bold>). At negative transmembrane voltages that favor CLC-1 closing, the E<sub>gate</sub> sidechain presumably moves to either the “middle” or “down” positions, or both, to occlude the channel pore.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Gating conformations in CLC transporters and channels.</title>
<p>(<bold>A</bold>) Cartoon depictions of the CLC anion-permeation pathway. The “gating glutamate” (E<sub>gate</sub>) can occupy anion binding sites within the permeation pathway (“down” and “middle” conformations, occupying the central (S<sub>cen</sub>) and external (S<sub>ext</sub>) anion-binding sites respectively) or away from these sites (“up” and “out” conformations). Coupling of E<sub>gate</sub> movement to Cl<sup>−</sup>/H<sup>+</sup> binding/unbinding and global conformational change generates 2:1 Cl<sup>−</sup>/H<sup>+</sup> exchange. (<bold>B</bold>) E<sub>gate</sub> is required for voltage-dependent gating in CLC channels but has been observed structurally only in CLC-1 (PDB ID: 6coy), in the “out” position. In contrast to CLC-1, which is predominantly open at zero mV, CLC-2 is predominantly closed. The open probability (P<sub>o</sub>) versus voltage (V) traces are based on published data reported for CLC-1 (<xref ref-type="bibr" rid="c56">Lisal and Maduke, 2008</xref>) and CLC-2 (<xref ref-type="bibr" rid="c90">Stolting et al., 2013</xref>).</p></caption>
<graphic xlink:href="553136v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>CLC-2, like CLC-1, is a voltage-gated channel, but with opposite voltage dependence, opening instead of closing in response to hyperpolarization (<xref ref-type="bibr" rid="c92">Thiemann et al., 1992</xref>; <xref ref-type="bibr" rid="c94">Wang et al., 2017</xref>). CLC-2 chloride channels are expressed in every mammalian organ, where they play diverse physiological functions (<xref ref-type="bibr" rid="c92">Thiemann et al., 1992</xref>; <xref ref-type="bibr" rid="c52">Lein et al., 2007</xref>; <xref ref-type="bibr" rid="c22">Duan, 2013</xref>; <xref ref-type="bibr" rid="c89">Stolting et al., 2014b</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). Perturbation of CLC-2 function is associated with human disease including leukodystrophies (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>), blindness (<xref ref-type="bibr" rid="c96">Xu et al., 2023</xref>), primary aldosteronism (<xref ref-type="bibr" rid="c32">Fernandes-Rosa et al., 2018</xref>; <xref ref-type="bibr" rid="c84">Scholl et al., 2018</xref>), and atrial fibrillation (<xref ref-type="bibr" rid="c43">Hansen et al., 2020</xref>). Despite their importance in human physiology, our understanding of CLC-2 molecular and physiological mechanisms is incomplete. A mystery concerning CLC-2 is why electrophysiological recordings of natively expressed channels reveal tremendous variation in voltage-dependent gating. CLC-2 currents are typically inwardly rectifying and activated by hyperpolarization, but the kinetics and degree of rectification are highly variable (<xref ref-type="bibr" rid="c10">Bosl et al., 2001</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). In some cases, this variability is understood – for example interactions between CLC-2 and the astrocytic GlialCAM protein yields voltage-independent currents (<xref ref-type="bibr" rid="c48">Jeworutzki et al., 2012</xref>; <xref ref-type="bibr" rid="c59">Maduke and Reimer, 2012</xref>). Yet many questions about CLC-2 gating remain.</p>
<p>Like CLC-1, CLC-2 gating depends critically on E<sub>gate</sub> (<xref ref-type="bibr" rid="c66">Niemeyer et al., 2003</xref>; <xref ref-type="bibr" rid="c12">Cederholm et al., 2010</xref>). At zero mV, CLC-2 is predominantly in the closed state (<xref ref-type="bibr" rid="c90">Stolting et al., 2013</xref>; <xref ref-type="bibr" rid="c89">Stolting et al., 2014b</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>), presumably with E<sub>gate</sub> blocking the pore. Such pore localization for E<sub>gate</sub> was modeled in a recent CLC-2 cryoEM structure (<xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>); however, experimental density for the sidechain was lacking, and therefore the precise structure of this gate remains uncertain (<bold><xref rid="fig1" ref-type="fig">Figure 1B</xref></bold>). Structures with improved resolution will be crucial to understanding CLC-2 gating, which involves interactions between E<sub>gate</sub>, Cl<sup>−</sup> and H<sup>+</sup>, with differential effects of external vs internal ions (<xref ref-type="bibr" rid="c78">Pusch et al., 1999</xref>; <xref ref-type="bibr" rid="c66">Niemeyer et al., 2003</xref>; <xref ref-type="bibr" rid="c82">Sanchez-Rodriguez et al., 2010</xref>; <xref ref-type="bibr" rid="c83">Sanchez-Rodriguez et al., 2012</xref>; <xref ref-type="bibr" rid="c19">De Jesus-Perez et al., 2016</xref>). In addition to the E<sub>gate</sub> mechanism, a “ball-and-chain” gating mechanism, in which the tethered N-terminus blocks the pore, has been proposed for CLC-2 (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>). However, this idea has been controversial (<xref ref-type="bibr" rid="c93">Varela et al., 2002</xref>) and the mechanism by which mutations in the N-terminal domain influence gating remains unknown. Because a structural foundation for understanding CLC-2 gating has been lacking, we determined cryoEM structures of CLC-2, in the presence and absence of the selective inhibitor AK-42 (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). The structures and complementary electrophysiology data presented here provide atomic insight into an N-terminal hairpin gating mechanism for CLC-2 channels.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Overview of cryoEM structure determination</title>
<p>Human CLC-2 (hCLC-2) protein was purified from cultured HEK293 GnTI<sup>-</sup> cells and further examined by cryoEM single particle analysis. Selected two-dimensional class averages showed a clear transmembrane domain embedded in a detergent micelle and features indicating an intracellular domain. Further refinement revealed a well-resolved transmembrane (TM) domain density at 2.46 Å, “CLC2-TM” (<bold><xref rid="fig2" ref-type="fig">Figure 2</xref></bold>; <bold><xref rid="fig2s1" ref-type="fig">Figure 2 - figure supplements 1</xref>-<xref rid="fig2s3" ref-type="fig">3</xref></bold>). Density for the C-terminal intracellular domain (CTD) is less well resolved. Such relatively weak density for the CTD relative to the TM domain was also observed in the cryoEM analysis of human CLC-1 (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>; <xref ref-type="bibr" rid="c95">Wang et al., 2019</xref>), which is hCLC-2’s closest homolog. The CTD of CLC-0, a CLC-1 ortholog from <italic>Torpedo mamorata</italic> (<xref ref-type="bibr" rid="c87">Steinmeyer et al., 1991</xref>) displays large movements in spectroscopic studies (<xref ref-type="bibr" rid="c11">Bykova et al., 2006</xref>; <xref ref-type="bibr" rid="c4">Alioth et al., 2007</xref>). Thus, conformational flexibility in the CTD appears to be a shared feature within this branch of the CLC family. To further characterize CTD map density, 3D classification was performed. Amongst ten 3D classes identified, two showed significantly improved density for the CTD. With non-uniform refinement and further local refinement, we determined two conformations of CLC-2 structures at 2.75 and 2.76 Å, respectively (<bold><xref rid="fig2s3" ref-type="fig">Figure 2 - figure supplement 3</xref></bold>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>CryoEM structure of the human CLC-2 channel.</title>
<p>Overall structure of the transmembrane domain (“CLC2-TM”) at 2.46 Å. The identical subunits of the homodimer are shown in purple and gray, Cl<sup>−</sup> ions are shown as green balls. (<bold>A</bold>) cryoEM density map with model overlay and (<bold>B</bold>) model only with dashed arrows indicating the locations of pathways detected by Caver: orange, primary Cl<sup>−</sup> pathway common to all CLCs; yellow, secondary Cl<sup>−</sup> pathway detected in CLC-2 and CLC-1. Details of the pathways are presented in <xref rid="fig3" ref-type="fig">Figure 3</xref>. The secondary pathway, whose function is not yet known, was so named when first observed in the CLC-1 structure (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>). (<bold>C</bold>) Zoomed-in views showing cryoEM density overlay of bound Cl<sup>−</sup> and key residues – E<sub>gate</sub> (E205) and inner-gate residues Ser<sub>C</sub> (S162) and Tyr<sub>C</sub> (Y553).S<sub>cen</sub> is indicated with a green dashed circle.</p></caption>
<graphic xlink:href="553136v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Structure of the transmembrane domain</title>
<p>The TM region of CLC-2 displays a typical CLC family homodimeric structure, with each subunit containing an independent Cl<sup>−</sup> pathway (<bold><xref rid="fig2" ref-type="fig">Figure 2A, B</xref></bold>). In the cryoEM map, clear density for the E<sub>gate</sub> residue (E205 in CLC-2) reveals it occupying the “down” position, at the S<sub>cen</sub> Cl<sup>−</sup> binding site (<bold><xref rid="fig2" ref-type="fig">Figure 2C</xref></bold>). This downward E<sub>gate</sub> positioning has previously been observed only in the x-ray crystallographic structure of the <italic>C. merolae</italic> CLC transporter homolog (cmCLC) (<xref ref-type="bibr" rid="c30">Feng et al., 2010</xref>), but not in any CLC channel homolog (<bold><xref rid="fig2s4" ref-type="fig">Figure 2 - figure supplement 4A,B</xref></bold>). In the recent CLC-2 structure by Ma et al., E<sub>gate</sub> lacked density and was modeled in two different conformations (<xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>) (<bold><xref rid="fig2s4" ref-type="fig">Figure 2 - figure supplement 4C</xref></bold>). Our cryoEM map also reveals a density feature at the S<sub>ext</sub> site, indicating a bound Cl<sup>−</sup> ion (<bold><xref rid="fig2" ref-type="fig">Figure 2C</xref></bold>). The ion is stabilized by surrounding backbone nitrogen atoms, a characteristic feature of CLCs.</p>
<p>In the down position, E<sub>gate</sub> physically occupies the S<sub>cen</sub> Cl<sup>−</sup> binding site, thus suggesting the structure represents a closed conformational state, as expected at zero mV (<bold><xref rid="fig1" ref-type="fig">Figure 1B</xref></bold>). To further evaluate the conformational state, we used Caver (<xref ref-type="bibr" rid="c16">Chovancova et al., 2012</xref>) to detect pathways through the protein. A continuous pathway through the protein could only be detected with a very small probe radius of 0.5 Å. In this case, the route detected follows the canonical Cl<sup>−</sup> transport pathway from the extracellular side to S<sub>cen</sub>, but then circumnavigates E<sub>gate</sub> to reach the intracellular pathway (<bold><xref rid="fig3" ref-type="fig">Figure 3A</xref>, movie 1</bold>). The pinch point of ∼0.7 Å near the E<sub>gate</sub> residue is too narrow for a Cl<sup>−</sup> ion and thus indicates a closed conformational state. The CLC-2 pathway is constricted compared to that in CLC-1, where the location of E<sub>gate</sub> in the “out” position permits a wider Cl<sup>−</sup> diffusion pathway (<bold><xref rid="fig3" ref-type="fig">Figure 3B</xref>, movie 2</bold>). Close-up views of the canonical Cl<sup>−</sup> pathway in CLC-2 and CLC-1 are shown in <bold><xref rid="fig3s1" ref-type="fig">Figure 3 - figure supplement 1</xref>.</bold></p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3</label>
<caption><p>Pore profile detected in CLC-2. (<bold>A</bold>) Left: The primary (orange) and secondary (yellow) pore detected in CLC-2 using Caver. Middle: The detected pore radii are displayed in dots as a color map. Right: Zoomed-in view of the restricted (narrowest) site of the pore profile, using the same coloring as in the middle panel. E<sub>gate</sub>, Ser<sub>C</sub> and Tyr<sub>C</sub> are shown as sticks. (<bold>B</bold>) Pore profile for CLC-1 (PDB ID:6coy), with display as in panel <bold>A</bold>.</p></caption>
<graphic xlink:href="553136v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>At the CLC inner-gate region, near conserved residues Tyr<sub>C</sub> (Y553) and Ser<sub>C</sub> (S162), the canonical (primary) Cl<sup>−</sup>permeation pathway is similar for CLC-2 and CLC-1 and wider than that seen in the CLC transporters (<bold><xref rid="fig3s2" ref-type="fig">Figure 3 - figure supplement 2A, B</xref>, movie 3</bold>). CLC-2 also displays a bifurcated pore, with a secondary pathway to the intracellular side, distinct from the primary pathway common to CLC family members. The secondary pathway is shared with CLC-1 but not seen in other CLC homologs of known structure. While the functional role of this distinctive secondary pore is not yet known, it is intriguing to note it is located near the region thought to act as a conduit for H<sup>+</sup> in the CLC transporters (<bold><xref rid="fig3s2" ref-type="fig">Figure 3 - figure supplement 2C</xref></bold>).</p>
</sec>
<sec id="s2c">
<title>Two conformations of the intracellular domain</title>
<p>All eukaryotic CLCs contain a pair of “cystathionine β-synthase” (CBS) domains in their intracellular C-terminal domain (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). CBS domains are found in a wide variety of functionally unrelated protein families, in all kingdoms of life, where they serve to regulate the activity of the attached protein (<xref ref-type="bibr" rid="c28">Ereno-Orbea et al., 2013</xref>; <xref ref-type="bibr" rid="c6">Anashkin et al., 2017</xref>). In the CLCs, mutations in or near the CBS domains alter channel gating and are associated with human disease, including myotonia, Dent’s disease, Bartter syndrome, osteopetrosis, leukoencephalopathy, retinal degeneration, lysosomal storage disease, and neurodevelopmental disorders (<xref ref-type="bibr" rid="c29">Estevez et al., 2004</xref>; <xref ref-type="bibr" rid="c37">Giorgio et al., 2017</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>; <xref ref-type="bibr" rid="c42">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="c64">Nicoli et al., 2019</xref>; <xref ref-type="bibr" rid="c5">Altamura et al., 2020</xref>; <xref ref-type="bibr" rid="c36">Gianesello et al., 2020</xref>; <xref ref-type="bibr" rid="c24">Duncan et al., 2021</xref>; <xref ref-type="bibr" rid="c100">Zifarelli, 2022</xref>; <xref ref-type="bibr" rid="c70">Palmer et al., 2023</xref>; <xref ref-type="bibr" rid="c96">Xu et al., 2023</xref>). Structurally, the CLC CBS domains interact across subunits, forming dimers of dimers and thus increasing the overall interaction area of the homodimer (<xref ref-type="bibr" rid="c30">Feng et al., 2010</xref>; <xref ref-type="bibr" rid="c71">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>; <xref ref-type="bibr" rid="c95">Wang et al., 2019</xref>; <xref ref-type="bibr" rid="c85">Schrecker et al., 2020</xref>). Structural rearrangement of the C-terminal domains is thought to occur during channel gating (<xref ref-type="bibr" rid="c97">Yamada et al., 2016</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>) and has been observed spectroscopically (<xref ref-type="bibr" rid="c11">Bykova et al., 2006</xref>; <xref ref-type="bibr" rid="c57">Ma et al., 2011</xref>), but no rearrangements have yet been observed at high resolution.</p>
<p>During the 3D classification data processing with a C1 reconstruction (no symmetry imposed), two distinct conformations were separated from the same CLC-2 dataset (<bold><xref rid="fig2s2" ref-type="fig">Figure 2 - figure supplement 2</xref></bold>). Structural comparison of these two classes reveals that they are very similar in the transmembrane domain, with RMSD of 0.58 Å and 0.42 Å for the two subunits. The main structural differences occur at the intracellular domain, with one class exhibiting a symmetric arrangement and the other, asymmetric. These two conformations are named as CLC2-CTDsym and CLC2-CTDasym, respectively (<bold><xref rid="fig4" ref-type="fig">Figure 4</xref></bold>, <bold><xref rid="fig4s1" ref-type="fig">Figure 4 - figure supplements 1</xref>,<xref rid="fig4s2" ref-type="fig">2</xref></bold>). In both classes, the CBS domains can be fit to the density, but the remaining residues 645-743 in the CLC-2 C-terminal domain are not observed and thus no Q scores (<xref ref-type="bibr" rid="c76">Pintilie et al., 2020</xref>) are computed (<bold><xref rid="fig4s1" ref-type="fig">Figure 4 - figure supplement 1</xref></bold>). In the asymmetric arrangement (CLC2-CTDasym), one of the CTDs rotates toward the TM region approximately 35° relative to the conformation in the symmetric structure (<bold><xref rid="fig4" ref-type="fig">Figure 4B</xref></bold>). Structural comparison focused on individual CTDs within the two classes reveals low RMSD values (∼1 Å), which indicates that the CTD undergoes a rigid body movement to accomplish the conformational change (<bold><xref rid="fig4" ref-type="fig">Figure 4C</xref></bold>, <bold>movie 4</bold>). Molecular dynamics (MD) simulations confirm conformational dynamics consistent with a domain rotation (<bold><xref rid="fig4s3" ref-type="fig">Figure 4 - figure supplement 3</xref></bold>). In both structures, the orientation of the CTD relative to the membrane is substantially different from that observed in other CLC structures (<bold><xref rid="fig4s4" ref-type="fig">Figure 4 - figure supplement 4</xref></bold>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Different conformations of the CTD.</title>
<p>(<bold>A</bold>). Overall structure of the two CLC-2 conformations. Left: CLC2-CTDsym at 2.75 Å. Right: CLC2-CTDasym at 2.76 Å. The subunits of the homodimer are shown in orange (CLC2-CTDsym) or yellow (CLC2-CTDasym) and gray (for both). The subunits adopting different CTD conformations are shown in orange and yellow, while the subunits sharing the same CTD conformation are shown in gray. The dashed line demarcates the transmembrane (TM) and cytoplasmic (CTD) domains. A hairpin structure detected at the intracellular pore is shown in blue. (<bold>B</bold>) Overlay of two conformations. (<bold>C</bold>) Hinge movement of the CTD between two conformations. The middle panel shows an overlay of CLC2-CTDsym (orange and gray) and CLC1-CTDasym (yellow and gray), with the CTDs highlighted in boxes. For the subunits that adopt different conformations (orange and yellow), the double-headed arrow indicates the change between the two conformations. The RMSD between the subunits shown in orange/yellow is 6.9 Å, while the RMSD for the subunits shown in gray is only 1.3 Å. Alignments of only the CTDs are shown at left and right; in these alignments, the low RSMD values (0.9 Å and 1.0 Å, respectively) indicate that the CTDs undergo a hinge movement.</p></caption>
<graphic xlink:href="553136v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>The hairpin structure corresponds to the N-terminal region</title>
<p>Another new feature of the determined CLC-2 structure is a hairpin density blocking the main Cl<sup>−</sup> pathway on the intracellular side (<bold><xref rid="fig4" ref-type="fig">Figure 4A</xref></bold>). This feature is not continuous with any other protein density in the map. In theory, such density could arise from a protein sequence on CLC-2 (from the unstructured N-or C-terminal regions) or from a separate protein carried along in the purification. Given the history of studies on CLC-2 gating, we first considered the CLC-2 N-terminal region.</p>
<p>Shortly after the initial cloning of CLC-2 (<xref ref-type="bibr" rid="c92">Thiemann et al., 1992</xref>), experiments on CLC-2 expressed in <italic>Xenopus</italic> oocytes demonstrated that deletion of an 18-residue segment of the N-terminus yielded a constitutively open channel, lacking the characteristic voltage-dependent gating of CLC-2, and that transplantation of this segment to the C-terminal domain restored gating (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>). Further, mutation of certain residues in the transmembrane domain (at a putative “receptor” site for the N-terminal blockade) also yielded an open-channel phenotype (<xref ref-type="bibr" rid="c49">Jordt and Jentsch, 1997</xref>). Based on these results, it was argued that CLC-2 has a “ball-and-chain” type gating mechanism reminiscent of that occurring in the <italic>Shaker</italic> potassium channel (<xref ref-type="bibr" rid="c99">Zagotta et al., 1990</xref>). However, experiments performed using the inside-out patch clamp configuration (<xref ref-type="bibr" rid="c78">Pusch et al., 1999</xref>) or using whole-cell recording with CLC-2 expressed in mammalian cells (<xref ref-type="bibr" rid="c93">Varela et al., 2002</xref>) failed to recapitulate the gating phenotype and called into question a ball-and-chain mechanism. Thus, while mutations in the N-terminus of CLC-2 influence gating, the precise mechanism-of-action has been uncertain.</p>
<p>Our cryoEM map allowed continuous modeling of the CLC-2 sequence starting from the first TM helix (residue 88). The lack of sufficient density for modeling residues 1-87 suggests that the N terminal cytoplasmic region of CLC-2 is intrinsically disordered. However, our observation of a resolvable hairpin density at the intracellular pore, together with the previous hypothesis of N-terminal ball-and-chain gating for CLC-2, prompted us to consider whether the hairpin density corresponds to N-terminal residues. We tested several candidate fragments from the CLC-2 N-terminal region and found that the hairpin density fits perfectly with residues corresponding to 14-28 (<bold><xref rid="fig5" ref-type="fig">Figure 5A</xref></bold>). Inspection of the Q-score validation plot for these residues shows they have higher values than the Q-score expected for the corresponding resolution (<bold><xref rid="fig5" ref-type="fig">Figure 5B</xref></bold>), which indicates reliable model building at this resolution (<xref ref-type="bibr" rid="c76">Pintilie et al., 2020</xref>). These residues are conserved throughout the mammalian CLC-2 homologs and partially conserved in <italic>Drosophila</italic> CLC-2 (<bold><xref rid="fig5s1" ref-type="fig">Figure 5 - figure supplement 1</xref></bold>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>The blocking hairpin structure corresponds to an N-terminal sequence of CLC-2.</title>
<p>(<bold>A</bold>). <italic>Left:</italic> The hairpin structure seen in the cryoEM density (blue mesh) fits N-terminal residues 14-28 (blue). <italic>Right:</italic> The subunit in CLC2-CTDasym structure that contains a CTD with rotated orientation lacks density for the hairpin structure. In this structure, the residues linking TM helices J and K are not resolved. The dark blue circles indicate this unresolved region (right panel) and the corresponding resolved J-K helix that occurs in the other subunits. (<bold>B</bold>) Model validation using Q-scores for the N-terminal hairpin: orange and light orange for subunits A &amp; B of CLC2-CTDsymsubunit; yellow for subunit A (the hairpin-containing subunit) of CLC2-CTDasym. The black line represents the expected Q-score at 2.75 Å based on the correlation between Q-scores and map resolution. (<bold>C</bold>) Residues on the transmembrane domain interact with the N-terminal hairpin. The J-K helical linker and TM Helices C, D, R, and J are labeled with arrows. Inset: Zoomed-in view of two hydrogen bonds formed between the hairpin structure and the TM domain: Q19-Q153 and T20-R363. Mutation of these two residues (Q25 and T26 in rat CLC-2) generated an open-channel phenotype for CLCCLC-2 expressed in <italic>Xenopus</italic> oocytes (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>).</p></caption>
<graphic xlink:href="553136v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Interestingly, the presence of the N-terminal hairpin is associated with conformational changes in the CTD and TM domains. In CLC2-CTDsym, N-terminal density was observed on both subunits. In CLC2-CTDasym, only the subunit whose CTD adopts the “symmetric” orientation (seen in CLC2-CTDsym) contains the hairpin density; in the subunit with the rotated CTD, no hairpin density is observed (<bold><xref rid="fig4" ref-type="fig">Figure 4</xref></bold>, <bold><xref rid="fig5" ref-type="fig">Figure 5A</xref></bold>). Along with the absence of hairpin density, the subunit with the rotated CTD exhibits a difference in the linker connecting transmembrane helices J and K, which is poorly resolved and insufficient for model building. In contrast, the subunits with the hairpin density contain reliable density in the JK-linker region, allowing confident modeling of an alpha helix (“JK-helix”, <bold><xref rid="fig5" ref-type="fig">Figure 5A</xref></bold>). This observation suggests that the JK-helix stabilizes the N-terminal hairpin peptide. Indeed, residues on the JK-helix interact directly with residues at the peptide’s hairpin turn (<bold><xref rid="fig5" ref-type="fig">Figure 5C</xref></bold>). Interactions with other regions in the TM domain (near helices C, D, J, and R) appear to further stabilize the hairpin in its binding site. MD simulations help separately validate the assignment and stability of the hairpin: in MD simulations initiated from the structure, we found that the N-terminus remained tightly associated with the channel in all simulations (<bold><xref rid="fig5s2" ref-type="fig">Figure 5 - figure supplement 2</xref></bold>).</p>
</sec>
<sec id="s2e">
<title>Functional support for pore block by the N-terminal hairpin structure</title>
<p>The hairpin structure appears to directly block the pore (<bold><xref rid="fig5s3" ref-type="fig">Figure 5 - figure supplement 3</xref></bold>). To evaluate the potential functional effect of pore block by the N-terminal hairpin, we performed whole-cell patch clamp recording on CLC-2, both WT and a deletion mutant lacking the hairpin residues (“Delta-N”), expressed in CHO cells. Delta-N CLC-2 exhibits currents that display less rectification and faster activation kinetics than WT CLC-2 (<bold><xref rid="fig6" ref-type="fig">Figure 6A-B</xref></bold>, <bold><xref rid="fig6s1" ref-type="fig">Figure 6 - figure supplement 1</xref></bold>). This gating phenotype is intermediate between the non-rectifying phenotype of N-deletion constructs from whole-cell recordings in oocytes (<xref ref-type="bibr" rid="c49">Jordt and Jentsch, 1997</xref>) and the highly rectifying phenotype from whole-cell recordings in HEK 293 cells (<xref ref-type="bibr" rid="c93">Varela et al., 2002</xref>). The Discussion section addresses the variability observed in CLC-2 current recordings. As was reported for N-deletion currents in oocytes, our Delta-N currents are substantially larger than WT currents, ∼6-fold on average when identical transfection conditions are used (<bold><xref rid="fig6" ref-type="fig">Figure 6C</xref></bold>). This difference cannot be explained by a difference in plasma-membrane expression, as surface biotinylation experiments revealed that expression levels of the two constructs are within 30% of one another (<bold><xref rid="fig6" ref-type="fig">Figure 6D, E</xref></bold>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6</label>
<caption><title>Patch-clamp experiments support CLC-2 channel block by the N-terminal hairpin structure.</title>
<p>(<bold>A</bold>) Representative currents from WT and Delta-N CLC-2, recorded using the whole-cell patch clamp configuration in response to the voltage protocol shown. (<bold>B</bold>) WT CLC-2 recording from panel A, shown on an expanded scale. (<bold>C</bold>) Summary of current levels measured for WT and Delta-N CLC-2 at the end of the 1-s voltage pulse to −100 mV. Data are from six independent transfection samples, in each case with WT and Delta-N recorded on the same day following transfection. WT: −600 ± 102 pA (SEM, n=8);Delta-N: −3300 ± 630 pA (SEM, n=8). (<bold>D</bold>) Western blot detection of biotinylated surface-expressed CLC-2 from three independent experiments. (<bold>E</bold>) Summary data for electrophysiology and surface-biotinylation experiments. (<bold>F</bold>) Representative examples of experiments to evaluate current run-up in WT and Delta-N CLC-2. <italic>Left panels:</italic> Time course data. Following an initial voltage-family measurement (I-V protocol as in panel A, taken at point “1”), currents were monitored by 1-s pulses to −100 mV every 5 s for five minutes, after which a second voltage-family measurement was made (point 2), followed by application of AK-42 to facilitate leak subtraction, and a final voltage-family measurement at point 3. I-V traces are shown at right. (<bold>G</bold>) Summary data for “run-up” experiments. <italic>Left panel:</italic> Normalized time-dependent currents for WT and Delta-N. Currents were first leak-subtracted (using the steady-state current after AK-42 application) and then normalized to the amplitude of the current measured in the first step of the 5-minute sequence. <italic>Right panels:</italic> Leak-subtracted current levels at −100 mV from “initial” and “final” IV traces measured at points “1” and “2’ in the time course (panel F). Average initial and final currents (pA ± SEM, n=8) are WT: −600 ± 102 and −1400 ± 260; Delta-N: −3300 ± 630 and −2900 ± 420).</p></caption>
<graphic xlink:href="553136v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Strikingly, WT but not Delta-N CLC-2 currents “run up” during recording sessions. In patch-clamp recording experiments, the term “run-up” describes a progressive increase in current that occurs after the initial measurement. To quantify CLC-2 run-up, we developed the following protocol: (1) on acquisition of whole-cell recording mode, an initial voltage-family of currents was recorded, as in <bold><xref rid="fig6" ref-type="fig">Figure 6A</xref></bold>; (2) from a holding potential of 0 mV, a single 1-s test pulse to −100 mV was repeated every 5 seconds to monitor time-dependent changes in current amplitude over 5 minutes, after which a second voltage-family of currents was recorded; (3) 300 nM AK-42 was added to selectively block all CLC-2 current (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>), and the steady state inhibition current was used for leak subtraction. In contrast to chloride-channel inhibitors historically used in electrophysiological experiments (<xref ref-type="bibr" rid="c86">Sepela and Sack, 2018</xref>), AK-42 is potent and highly selective for CLC-2 over other anion channels (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). Representative current traces and summary data for this set of experiments are shown in <bold><xref rid="fig6" ref-type="fig">Figure 6F, G</xref></bold>; individual I-V traces are shown in <bold><xref rid="fig6s1" ref-type="fig">Figure 6 - figure supplement 1</xref></bold>. The increase in WT but not Delta-N CLC-2 currents over time is consistent with an “unblocking” of the pore by release of the N-terminal hairpin peptide.</p>
<p>The increase in WT currents is accompanied by an apparent decrease in channel rectification, towards the level displayed by Delta-N CLC-2. WT CLC-2 currents recorded in heterologous and native expression systems are generally highly inwardly rectifying. Analogous to a rectifier in an electrical circuit, WT CLC-2 acts as a directional current valve, allowing much larger absolute currents to flow at negative membrane potentials compared to positive ones. At the beginning of each recording, our WT CLC-2 currents display such inward rectification, but this characteristic appears to diminish during five minutes of repeated voltage pulsing to −100 mV, as substantial currents at positive voltages appear. For the experiment shown in <bold><xref rid="fig6" ref-type="fig">Figure 6F</xref></bold>, the steady-state current at +80 mV increases from 161 pA to 902 pA, almost six-fold, compared to a 2.4-fold increase at −100 mV. This observation is surprising because WT CLC-2 has been characterized as passing little to no current at positive voltages (<xref ref-type="bibr" rid="c73">Park et al., 1998</xref>; <xref ref-type="bibr" rid="c7">Arreola et al., 2002</xref>). We initially considered that the increase in current at +80 mV could be due to the patch-clamp seal becoming leaky over time or that a background channel is being activated; however, such ‘leak’ currents would not be expected to be blocked by the small molecule inhibitor AK-42, which is highly selective for CLC-2 over all other CLCs and anion channels (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). AK-42 block of the augmented +80 mV currents seen at the end of each WT CLC-2 recording supports the idea that the hairpin peptide may contribute to the inward rectification of CLC-2 (<bold><xref rid="fig6" ref-type="fig">Figure 6F</xref></bold>, <bold><xref rid="fig6s2" ref-type="fig">Figure 6 - figure supplement 2</xref></bold>).</p>
</sec>
<sec id="s2f">
<title>AK-42 bound structure</title>
<p>AK-42’s selectivity empowered our biophysical studies of CLC-2 and will also be invaluable for studies of CLC-2’s physiological function. We determined the structure of CLC-2 in complex with AK-42 (<bold><xref rid="fig7" ref-type="fig">Figure 7</xref></bold>). While the TM domain could be resolved to 2.7 Å, the CTD exhibited poor density compared to the apo sample and did not allow us to confidently model the CTD when masking the whole protein for refinement. To improve the density quality, we masked the CTD only for refinement; this masking provided an acceptable density map at 4 Å and allowed us to confidently dock the CTD from apo structure (<bold><xref rid="fig7s1" ref-type="fig">Figure 7 - figure supplements 1</xref>-<xref rid="fig7s4" ref-type="fig">4</xref></bold>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7</label>
<caption><title>Bound AK-42 blocks the Cl<sup>−</sup> pathway in CLC-2.</title>
<p>(<bold>A</bold>) TM-domain structure of the CLC-2 structure in complex with AK-42 (CLC2-TM-AK42) at 2.74 Å. The identical subunits of the homodimer are shown in hot pink and gray; Cl<sup>−</sup> ions are shown as green balls. Bound AK-42 is highlighted with a yellow circle on the pink subunit. The cyan arrow indicates the Cl<sup>−</sup> pathway. (<bold>B</bold>) Zoomed-in view of the AK-42 binding site. (<bold>C</bold>) A sliced view of CLC-2 showing AK-42 (yellow carbon atoms; CPK coloring on non-carbon atoms) and E<sub>gate</sub> (CPK sticks). Both AK-42 and E<sub>gate</sub> obstruct the Cl<sup>−</sup> pathway, displayed as a color map.</p></caption>
<graphic xlink:href="553136v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Like the apo CLC-2 structure, the TM domain of CLC2-TM-AK42 is well-resolved with clear densities for AK-42 and for CLC-2 sidechains, including the E<sub>gate</sub> sidechain (<bold><xref rid="fig7s5" ref-type="fig">Figure 7 - figure supplements 5</xref>,<xref rid="fig7s6" ref-type="fig">6</xref></bold>). The overall density for CLC2-TM-AK42 is very similar to that observed in apo CLC-2, but with an extra density that fits very well to the AK-42 molecule (<bold><xref rid="fig7" ref-type="fig">Figure 7B</xref>, Movie 5</bold>). Residues in the AK-42 binding pocket exhibit little conformational change between the apo and AK-42 bound CLC-2 structures. The exception is residue M460, which moves ∼3 Å to avoid a clash with AK-42’s phenyl ring (<bold><xref rid="fig7s7" ref-type="fig">Figure 7 - figure supplement 7</xref></bold>). Located at the extracellular side of Cl<sup>−</sup> pathway, the bound AK-42 appears to directly block Cl<sup>−</sup> permeation (<bold><xref rid="fig7" ref-type="fig">Figure 7C</xref></bold>). This AK-42 binding pocket is the same as observed in the docking prediction we previously made using a CLC-2 homology model (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). In that docking study, the top docking poses varied in detail, and therefore the specific interactions were not certain, but the general position of the binding site is confirmed by our cryoEM structure. Two conformations were found to fit the density well with the carboxyl group on opposite sides. They were tested using the Quantum Mechanical Restraints (QMR) method (<xref ref-type="bibr" rid="c55">Liebschner et al., 2023</xref>); one had significantly lower energy (∼17 kcal/mol) and strain on the ligand (10.2 kcal/mol), considering the ligand and nearby residues only. For the lower energy conformation, the Q-scores of AK-42 in the map are 0.74 and 0.76 in the two subunits, respectively. Both are higher than the expected Q-score at this resolution (0.64), which indicates a good fit of AK-42 to the cryoEM density (<xref ref-type="bibr" rid="c76">Pintilie et al., 2020</xref>). A similar AK-42 binding pose was observed in another recently published structure of CLC-2 (<xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>).</p>
<p>In the binding site, AK-42’s phenyl ring nestles into a hydrophobic pocket lined by F306, F463, F459, M460 and L524 (<bold><xref rid="fig7" ref-type="fig">Figure 7B</xref></bold>). The carboxyl group of AK-42 forms hydrogen bonds with the side chain of S392 and backbone of K394 (<bold><xref rid="fig7" ref-type="fig">Figure 7B</xref></bold>). These polar interactions are consistent with mutagenesis data. At 30 nM AK-42, inhibition of S392A is reduced ∼50% compared to WT, consistent with disruption of the observed hyodrgen bond, while inhibition of K394A is not significantly different from WT, consistent with a backbone rather than a side-chain interaction (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>; <xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>). A third hydrogen bond – between K204 and the pyridine nitrogen of AK-42 – also contributes to AK-42’s stability in the binding pocket. A pivotal role for the pyridine nitrogen was discovered during the development of AK-42, where it was found that inhibitor potency is increased by over two orders of magnitude by addition of a nitrogen at this position but not by addition of a nitrogen at any other position in the ring (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). The interaction of this pyridine nitrogen with K204 is supported by mutagenesis data, which shows that inhibition of K204M and K204R (K210M and K210R in rat CLC-2) is reduced ∼3-fold compared to WT (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>; <xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>). The distance between the nitrogen atoms on K204 and AK-42 is 3.6 Å, within acceptable hydrogen bond distance, while the distances between K204 and any other atoms on AK-42 are too far to allow hydrogen bond formation.</p>
<p>Notably, density corresponding to the N-terminal hairpin structure is not seen in the AK-42 bound structure. After intensive 3D classification, only very minimal hairpin density was observed in a few classes. It thus appears that the majority of AK-42 bound CLC-2 particles have a flexible N-terminus that is not blocking the Cl<sup>−</sup> pathway. There is no obvious explanation for this difference compared to the apo structure. The orientation of the CTD in the AK-42 bound structure is the same as observed in the apo structure that shows N-terminal hairpin binding; the density for the J-K helix is weaker than in the apo dataset, but still sufficient to allow modeling of the helix. The TM regions also appear similar. To scrutinize for subtle conformational changes, we calculated a distance difference matrix (<xref ref-type="bibr" rid="c68">Nishikawa, 1972</xref>) comparing CLC2-TM and AK-42 bound CLC-2 (<bold><xref rid="fig7s8" ref-type="fig">Figure 7 - figure supplement 8</xref></bold>). The minor changes observed do not readily suggest a structure-based hypothesis for the observed difference in N-terminus. It could be that AK-42 inhibits dynamics that are essential for hairpin peptide binding.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Our CLC-2 channel structures display quintessential CLC characteristics, including a homodimeric arrangement of subunits, transmembrane domains composed of 18 helical segments, and conserved residues surrounding central anion-binding sites S<sub>ext</sub> and S<sub>cen</sub> (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). At 2.5 Å resolution, we observe clear density for critical features, including a Cl<sup>−</sup> ion at S<sub>ext</sub> and the E<sub>gate</sub> residue at S<sub>cen</sub> (<bold><xref rid="fig2" ref-type="fig">Figure 2C</xref></bold>). In this position, E<sub>gate</sub> blocks the pore, generating a closed conformational state – as expected for CLC-2 at 0 mV (<bold><xref rid="fig1" ref-type="fig">Figure 1</xref></bold>).</p>
<sec id="s3a">
<title>AK-42 binding site and inhibition potency</title>
<p>A distinctive feature of AK-42—unique amongst CLC inhibitors—is its high selectivity for CLC-2 versus other channels, transporters, and receptors (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>). The IC<sub>50</sub> for inhibition of CLC-2 by AK-42 (17 nM) is more than four orders of magnitude lower than the IC<sub>50</sub> for inhibition of CLC-1, CLC-2’s closest homolog. CLC-1 and CLC-2 are 50% identical overall, and within the AK-42 binding site only five residues are different (<bold><xref rid="fig7s9" ref-type="fig">Figure 7 - figure supplement 9</xref></bold>). Structural comparison of CLC-1 (PDB ID:6coy) with CLC2-AK42 reveals that these five residues (I112 (S139), S392 (M419), Q393 (P420), K394 (R421), and L397 (I424)) exhibit only relatively minor differences in backbone conformation. While the S392 side chain contributes to a hydrogen-bond interaction with AK-42 (<bold><xref rid="fig7" ref-type="fig">Figure 7B</xref>)</bold>, which M419 in CLC-1 cannot provide, this interaction alone cannot explain the four orders of magnitude difference in AK-42 potency. Indeed, the mutation S392A reduces inhibition by AK-42 (30 nM) only ∼3-fold (<xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>). Similarly, Q393P (Q399P in rat CLC-2) reduces inhibition by less than five-fold (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>; <xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>). A steric clash between F279 (F252 in CLC-2) and the benzyl substituent in AK-42 may also contribute to the lack of potency of AK-42 towards CLC-1 (<bold><xref rid="fig7s9" ref-type="fig">Figure 7 - figure supplement 9</xref></bold>). In CLC-2, this same residue (F252) is shifted away from the binding site, opening a sub-pocket that the benzyl group occupies. This difference is not simply induced by AK-42 binding, as F252 is also shifted away from the binding site in the CLC-2 apo structure. In the structure-activity relationship studies used to develop AK-42, the benzyl substituent increased selectivity approximately 5-fold (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>), thus supporting the significance of this interaction to selectivity. Unfortunately, this hypothesis cannot be tested through mutagenesis experiments due to the extremely low expression of F252 mutants (Ma, 2023).</p>
<p>The pathway from the extracellular solution appears sufficiently wide for AK-42 to worm its way into the binding site (<bold><xref rid="fig7" ref-type="fig">Figure 7C</xref></bold>). It is not yet known whether this pathway becomes wider in the CLC-2 open state nor whether inhibition by AK-42 is state-dependent. Studies to address this question would be valuable for understanding CLC-2 conformational change and gating dynamics.</p>
</sec>
<sec id="s3b">
<title>E<sub>gate</sub> conformation</title>
<p>CLC-2 is the first CLC channel homolog to be seen in a closed conformational state. While it was expected that E<sub>gate</sub> would localize to the Cl<sup>−</sup>-permeation pathway in the closed conformational state, it was not certain whether the S<sub>ext</sub> or S<sub>cen</sub> site would be preferred. The structure of CLC-1 provides an argument that S<sub>ext</sub> might be preferred. In CLC-1, anion density is observed at S<sub>ext</sub> but not at S<sub>cen</sub> (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>). It was hypothesized that the lack of density at S<sub>cen</sub> in CLC-1 may reflect a reduced anion-binding affinity that contributes to increased Cl<sup>−</sup> conduction (higher Cl<sup>−</sup> throughput) by the channels compared to the transporters (<xref ref-type="bibr" rid="c72">Park and MacKinnon, 2018</xref>), as all structures of WT CLC transporters show anion density (either Cl<sup>−</sup> or E<sub>gate</sub>) at both S<sub>ext</sub> and S<sub>cen</sub> (<xref ref-type="bibr" rid="c26">Dutzler et al., 2003</xref>; <xref ref-type="bibr" rid="c13">Chavan et al., 2020</xref>; <xref ref-type="bibr" rid="c85">Schrecker et al., 2020</xref>). If true for all channels, one might expect E<sub>gate</sub> in CLC-2 to occupy S<sub>ext</sub> rather than S<sub>cen</sub> in the closed state; however, we do not observe this, suggesting that decreased anion affinity at S<sub>cen</sub> is not the universal reason for increased Cl<sup>−</sup> conduction in CLC channels relative to the transporters. It is unlikely that E<sub>gate</sub> is protonated in our structures, as neutralization of E<sub>gate</sub> in CLC-2 leads to open-channel phenotypes (<xref ref-type="bibr" rid="c66">Niemeyer et al., 2003</xref>; <xref ref-type="bibr" rid="c21">de Santiago et al., 2005</xref>). Our CLC-2 structure is consistent with the predictions made by Arreola and colleagues, who used homology modeling in concert with detailed electrophysiological analyses to conclude that the CLC-2 gate is formed by the E<sub>gate</sub>-Tyr<sub>C</sub> pair at S<sub>cen</sub> (<xref ref-type="bibr" rid="c20">De Jesus-Perez et al., 2021</xref>). Additional experiments, to directly measure anion affinity and to determine structures of CLC-2 and CLC-1 in both open and closed conformations are needed to better understand these channels’ similarities and differences.</p>
</sec>
<sec id="s3c">
<title>CTD conformation</title>
<p>CLC-2 is also the first CLC in which two conformations of the CTD are observed. While many previous studies indicate that conformational change of the CTDs plays a critical role in CLC gating (<xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>; <xref ref-type="bibr" rid="c40">Grieschat et al., 2020</xref>), the mechanistic details are currently fuzzy. Unlike other CLC variants, CLC-2 can still conduct Cl<sup>−</sup> when its CTD is removed; however, the modified gating kinetics of this mutant do suggest a role of the CTD in regulating channel function (<xref ref-type="bibr" rid="c35">Garcia-Olivares et al., 2008</xref>). The impact of mutations in various regions of the CLC-2 CTD further supports its role in gating (<xref ref-type="bibr" rid="c98">Yusef et al., 2006</xref>; <xref ref-type="bibr" rid="c74">Paul et al., 2007</xref>; <xref ref-type="bibr" rid="c90">Stolting et al., 2013</xref>; <xref ref-type="bibr" rid="c37">Giorgio et al., 2017</xref>), as do the effects of ATP binding on channel kinetics (<xref ref-type="bibr" rid="c80">Saint-Martin et al., 2009</xref>; <xref ref-type="bibr" rid="c90">Stolting et al., 2013</xref>). While we do not see ATP bound in our structure (none was added to the protein preparation), the binding-site region overlaps reasonably well with the structure of the ATP-bound CLC-5 CTD (<bold><xref rid="fig4s5" ref-type="fig">Figure 4 - figure supplement 5</xref></bold>). The physiological significance of an intact CTD is underscored by CTD mutations and truncations of CLC-2 that occur in human leukoencephalopathy and retinal degeneration (<xref ref-type="bibr" rid="c37">Giorgio et al., 2017</xref>; <xref ref-type="bibr" rid="c42">Guo et al., 2019</xref>; <xref ref-type="bibr" rid="c96">Xu et al., 2023</xref>). It is likely that the structural rearrangement we observe strongly influences channel gating: the CTD upward hinge rotation restricts access to the hairpin-blocking site and substantially changes CTD interactions with the transmembrane domain.</p>
</sec>
<sec id="s3d">
<title>Ball and Chain Gating</title>
<p>Steric block of the Cl<sup>−</sup> permeation pathway by the N-terminal hairpin peptide (<bold><xref rid="fig5" ref-type="fig">Figure 5</xref></bold>) rekindles the hypothesis of a “ball-and-chain”-type gating mechanism for CLC-2, first proposed over 20 years ago (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>). In those studies, residue Q19 in the N-terminal hairpin, which hydrogen bonds to Q153 in the TM domain (<bold><xref rid="fig5" ref-type="fig">Figure 5C</xref></bold>), was identified as a residue critical to the “ball” blocking mechanism (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>). In follow-up studies, it was concluded that the “receptor” site on the TM domain is formed by residues in a stretch from 342-351 (<xref ref-type="bibr" rid="c49">Jordt and Jentsch, 1997</xref>) on helix J, which also forms part of the hairpin-docking site (<bold><xref rid="fig5" ref-type="fig">Figure 5C</xref></bold>, <bold><xref rid="fig5s4" ref-type="fig">Figure 5 - figure supplement 4A</xref></bold>). The hairpin-TM interface identified in our structure also exquisitely harmonizes with results from studying human mutations associated with primary aldosteronism. These gain-of-function mutations, which map squarely onto the peptide hairpin and surrounding TM region (<bold><xref rid="fig5s4" ref-type="fig">Figure 5 - figure supplement 4B</xref></bold>), cause increases in CLC-2 currents that depolarize the glomerulosal membrane potential thus leading to disease (<xref ref-type="bibr" rid="c32">Fernandes-Rosa et al., 2018</xref>; <xref ref-type="bibr" rid="c84">Scholl et al., 2018</xref>).</p>
<p>Our electrophysiology results also support a ball-and-chain gating mechanism. First, we demonstrate that the increase in current in hairpin-deleted channels reflects an increase in channel activity rather than an increase in surface expression (<bold><xref rid="fig6" ref-type="fig">Figure 6D,E</xref></bold>), consistent with loss of a channel-closing mechanism. Second, we show that WT but not Delta-N CLC-2 currents increase over time (<bold><xref rid="fig6" ref-type="fig">Figure 6F,G</xref>)</bold>, consistent with relief of hairpin block. Importantly, our use of the selective inhibitor AK-42 (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>) provides confidence that the current increase is specific to CLC-2 and not a result of leak or a run-up of other Cl<sup>−</sup> currents, which notoriously lurk in all mammalian cells and can confound interpretation of experimental results. In the context of our structure and the mutagenesis studies discussed above, our electrophysiological results fortify a ball-and-chain model for CLC-2 gating.</p>
</sec>
<sec id="s3e">
<title>Revised framework for CLC-2 gating</title>
<p>All CLC channel homologs are homodimers that have two gating mechanisms, one acting on individual pores within each subunit (“protopore” gating) and one that opens and closes both pores (“common” gating) (<xref ref-type="bibr" rid="c102">Zuniga et al., 2004</xref>; <xref ref-type="bibr" rid="c15">Chen, 2005</xref>; <xref ref-type="bibr" rid="c101">Zifarelli and Pusch, 2007</xref>; <xref ref-type="bibr" rid="c61">Miller, 2014</xref>; <xref ref-type="bibr" rid="c89">Stolting et al., 2014b</xref>, <xref ref-type="bibr" rid="c88">a</xref>; <xref ref-type="bibr" rid="c1">Accardi, 2015</xref>). Protopore gating is controlled by E<sub>gate</sub> (<bold><xref rid="fig1" ref-type="fig">Figure 1</xref></bold>), with voltage-dependence arising from interactions between E<sub>gate</sub> and ions in the pore (<xref ref-type="bibr" rid="c78">Pusch et al., 1999</xref>; <xref ref-type="bibr" rid="c66">Niemeyer et al., 2003</xref>; <xref ref-type="bibr" rid="c65">Niemeyer et al., 2009</xref>; <xref ref-type="bibr" rid="c82">Sanchez-Rodriguez et al., 2010</xref>; <xref ref-type="bibr" rid="c83">Sanchez-Rodriguez et al., 2012</xref>; <xref ref-type="bibr" rid="c19">De Jesus-Perez et al., 2016</xref>). Common gating is thought to involve structural rearrangements at the subunit interfaces and in the cytoplasmic domains (<xref ref-type="bibr" rid="c14">Chen, 1998</xref>; <xref ref-type="bibr" rid="c77">Pusch, 2002</xref>; <xref ref-type="bibr" rid="c23">Duffield et al., 2003</xref>; <xref ref-type="bibr" rid="c11">Bykova et al., 2006</xref>; <xref ref-type="bibr" rid="c57">Ma et al., 2011</xref>). In CLC-2, common and protopore gating are highly coupled (<xref ref-type="bibr" rid="c102">Zuniga et al., 2004</xref>; <xref ref-type="bibr" rid="c21">de Santiago et al., 2005</xref>; <xref ref-type="bibr" rid="c20">De Jesus-Perez et al., 2021</xref>). Our structural data provides a new framework for understanding these gating mechanisms (<bold><xref rid="fig8" ref-type="fig">Figure 8</xref></bold>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Structural framework for CLC-2 gating.</title>
<p>CLC-2’s gating is illustrated based on our new structural data. Ball and chain gating is coupled to conformational change of the CTD, with CTD rotation precluding pore block by the N-terminal hairpin. Electrophysiological studies showing that removal of the CTD speeds CLC-2 activation and deactivation kinetics (<xref ref-type="bibr" rid="c8">Arreola et al., 2008</xref>; <xref ref-type="bibr" rid="c35">Garcia-Olivares et al., 2008</xref>) are consistent with this structural model. Localized E<sub>gate</sub> motions control protopore gating within each subunit. Coupling between E<sub>gate</sub> and the hairpin/CTD may underlie coupling between protopore and common gating observed in electrophysiological studies (<xref ref-type="bibr" rid="c102">Zuniga et al., 2004</xref>; <xref ref-type="bibr" rid="c21">de Santiago et al., 2005</xref>; <xref ref-type="bibr" rid="c20">De Jesus-Perez et al., 2021</xref>).</p></caption>
<graphic xlink:href="553136v1_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s3f">
<title>Ball-and-chain gating as a potential mechanism for CLC-2 current variability</title>
<p>How do we explain the ostensible discrepancy between our results, which support a ball-and-chain model, and the previously published results that were used to argue against a ball-and-chain type gating mechanism? We think the discrepancy is not as dire as it originally seemed. The previous discrepancy is as follows. In studies of an N-terminal CLC-2 deletion mutant in HEK 293 cells, Varela et al. observed currents that differed depending on whether whole-cell or nystatin-perforated patch clamp recording was used: with whole-cell recording, deletion-mutant currents displayed rectification similar to WT CLC-2 but with much faster kinetics; with perforated-patch recording, currents were voltage independent and non-rectifying (<xref ref-type="bibr" rid="c93">Varela et al., 2002</xref>). At the time, this difference was interpreted to mean that the open-channel phenotype (and therefore ball-and-chain gating) was artifactual, due to a diffusible intracellular factor binding to the N-terminal deletion channel, but not the WT channel, locking it open in the perforated-patch recording configuration (but diffusing away in whole-cell recording experiments). However, Varela et al. also aptly pointed out that mutagenesis experiments did support a role for the CLC-2 N-terminus in channel gating. Further, they noted that the different results between their two recording configurations could be due to differences of physiological relevance, such as osmotic forces and/or channel-cytoskeleton interactions (<xref ref-type="bibr" rid="c41">Grunder et al., 1992</xref>; <xref ref-type="bibr" rid="c3">Ahmed et al., 2000</xref>). Such factors could also explain the differences between our whole-cell recordings and those of Varela et al. We note that our Delta-N currents observed with whole-cell recording (<bold><xref rid="fig6s1" ref-type="fig">Figure 6 - figure supplement 1</xref></bold>) are similar to currents displayed by the aldosteronism peptide-hairpin mutant G24D in perforated-patch clamp recordings (<xref ref-type="bibr" rid="c39">Goppner et al., 2019</xref>), supporting that our use of whole-cell recording is not introducing an artifact.</p>
<p>We hypothesize that sensitivity of ball-and-chain gating to physiological variables may underlie the tremendous variation in kinetics and voltage-dependence observed amongst recordings of natively expressed CLC-2 (<xref ref-type="bibr" rid="c10">Bosl et al., 2001</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). Such variation could arise from differences in one or more of the factors known to modulate CLC-2 gating – osmotic forces, transmembrane voltage, ATP, phosphorylation, or interactions with the cytoskeleton or other cellular proteins (<xref ref-type="bibr" rid="c67">Nighot et al., 2017</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>; <xref ref-type="bibr" rid="c69">Okamoto et al., 2019</xref>) – and could be further modulated by the expression of N-terminal splice variants (<xref ref-type="bibr" rid="c33">Furukawa et al., 1995</xref>; <xref ref-type="bibr" rid="c17">Cid et al., 2000</xref>). We propose that mechanistic studies of the CLC-2 gating run-up we report here (<bold><xref rid="fig6" ref-type="fig">Figure 6F</xref></bold>) will be valuable to guide studies on the variability of CLC-2 currents in native systems and how it relates to ball-and-chain gating.</p>
</sec>
<sec id="s3g">
<title>Summary</title>
<p>The structures and electrophysiological data presented here support a ball-and-chain mechanism for CLC-2 gating and offer a framework for understanding the tight coupling between common and protopore gating in CLC-2. In addition, the structures illuminate details for molecular recognition by the selective inhibitor AK-42, the first and currently only known small-molecule modulator that is both potent and selective for a CLC family member.</p>
</sec>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Molecular biology and AK-42 synthesis</title>
<p>Full-length human CLC-2 (Uniprot ID: P51788) was fused to a C-terminal twin-strep tag with a linker of 5’-TCGAATTCT<underline>TTGGAAGTTTTGTTTCAAGGTCCA</underline>ACTGCTGCCGCCGCT-3’ containing a HRV 3C protease cleavage sequence (underlined). This human C-terminal twin-strep-tagged CLC-2 fusion construct was cloned into a modified pFastBac vector that contains a CMV promoter for protein expression in mammalian cells (<xref ref-type="bibr" rid="c38">Goehring et al., 2014</xref>; <xref ref-type="bibr" rid="c71">Park et al., 2017</xref>). For electrophysiology and cell surface protein biotinylation/isolation experiments, the twin-strep tag was replaced by a EGFP tag. A C-terminal GFP tag was previously shown to have no significant effect on CLC-2 channel kinetics or voltage dependence (Park, Arreola 1998). In the N-terminal deletion CLC-2 (Delta-N), residues 14-27 (ALQYEQTLMYGRYT) were removed from full-length (WT) CLC-2.</p>
<p>AK-42 was synthesized and quantified as previously described (<xref ref-type="bibr" rid="c51">Koster et al., 2020</xref>)</p>
</sec>
<sec id="s4b">
<title>Protein expression/ purification</title>
<p>The full-length CLC-2 construct was transformed to DH10Bac competent cells (Invitrogen) to isolate baculovirus bacmid. The bacmid was transfected to sf9 cells using Cellfectin-II (Invitrogen) to produce baculovirus. The baculovirus were then further amplified twice in sf9 cells. The protein was expressed with HEK293 GnTI<sup>-</sup> cells with the amplified baculovirus. HEK293 GnTI<sup>-</sup> cells were cultured in Freestyle 293 medium (Invitrogen) supplemented with 2% FBS on a shaker at 37 °C in the presence of 8% CO<sub>2</sub> to a density of 3 × 10<sup>6</sup> cells per ml, then infected with 5% v/v baculovirus. After culturing for another 8-16 hours, sodium butyrate was added at final concentration of 10 mM, then further expressed for 48 hours at 37 °C before harvest. Cells were pelleted and stored at −80 °C.</p>
<p>Frozen cell pellets were resuspended in resuspension buffer containing 50 mM Hepes, pH 7.5, 300 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA), and 1 protease inhibitor cocktail tablet (MedChem Express), then briefly lysis cells with dounce homogenizer for 10-15 times. Cellular debris were collected by centrifugation at 18k rpm for 30 minutes at 4 °C, and then resuspended with resuspension buffer supplemented with 1% lauryl maltose neopentyl glycol (LMNG) and 0.1% cholesteryl semisuccinate (CHS). After extraction for 2 hours, the lysate was centrifuged at 18k rpm for 40 minutes at 4 °C. The clarified lysate was incubated with 1 mL of strep-Tacin XT high-capacity resin (IBA) for 2 hours at 4 °C. Resin was washed with wash buffer containing 50 mM Hepes, pH 7.5, 300 mM NaCl, 1 mM DTT, 1 mM EDTA, 0.02% LMNG, and 0.002% CHS. Purified protein was released from resin with 50 µg HRV 3C protease and incubated at 4 °C for overnight. The retrieved protein was concentrated to 0.5 ml with Amicon Ultra (50 kDa cutoff, EMD Millipore) and followed by size-exclusion chromatography (SEC) using a superdex 200 Increased 10/300 chromatography column on an AKTA Purifier 10 FPLC system (GE Healthcare) with buffer containing 20 mM Hepes, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 0.002% LMNG, and 0.0002% CHS. Protein fractions were pooled, concentrated with Amicon Ultra (50 kDa cutoff, EMD Millipore) to ∼5 mg/ml, and immediately used for cryoEM grid preparation.</p>
<p>For CLC-2 and AK-42 complex, AK-42 was first dissolved in DMSO to 45 mM, then further diluted with CLC-2 SEC buffer to 2 mM and mixed with purified and concentrated CLC-2 protein (2.9 mg/mL) to make final solution with CLC-2/AK-42 at a molar ratio of 1:10 (20 μM CLC-2 with 200 μM AK-42). The mixture was incubated at 4 °C for 3 hours and then used for cryoEM grid preparation.</p>
</sec>
<sec id="s4c">
<title>CryoEM data collection and processing</title>
<p>Three microliters of the purified CLC-2 or CLC-2/AK-42 mixture was applied to glow-discharged copper Quantifoil R1.2/1.3 or R2/1 holey carbon grids (Quantifoil). Grids were incubated for 15 s, then blotted for 4s or 6s at 100% humidity, then plunge-frozen in liquid-nitrogen-cooled liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific) at 4 °C.</p>
<p>The grids were imaged on a Titan Krios electron microscope (Thermo Fisher) operated at 300 kV with a Falcon 4 direct electron detector (Thermo Fisher Scientific) and SelectrisX energy filter (Thermo Fisher Scientific). Micrographs were recorded at a magnification of 130,000 × (pixel size of 0.946 Å per pixel) with EPU software (Thermo Fisher Scientific) Each image was composed of 40 individual frames with total cumulative dose of 50 e<sup>-</sup> per Å<sup>2</sup>. For CLC-2 dataset, images were collected with an exposure time of 7.5 seconds and a dose rate of 6.7 e<sup>-</sup> per second per Å<sup>2</sup> (OR 6.0 e<sup>-</sup> per second per pixel). For CLC-2/AK-42 dataset, images were collected with an exposure time of 5.6 seconds and a dose rate of 8.9 e<sup>-</sup> per second per Å<sup>2</sup> (OR 8.0 e<sup>-</sup> per second per pixel). Defocus values were set from −1.0 μm to −2.0 μm.</p>
<p>CryoEM data processing was performed mainly using CryoSPARC 3.2 (Structura Biotechnology Inc), except those mentioned specifically. For CLC-2 sample, a total of 14,198 movie stacks were subjected to motion correction. The contrast-transfer function (CTF) parameters were estimated using patch CTF. Initially, a total of 56,091 particles were auto-picked and subjected to reference-free 2D classification. A total of 7 class averages were selected as templated for automated particle picking. A total of 4,999,780 particles were auto-picked and extracted with a box size of 256 pixels. The extracted particles were then subjected to 2D classification to remove ice, contaminants, and aggregates. The following ab initio reconstruction and 3D refinement are all performed with C1 symmetry. The cleared-up classes were used for ab initio reconstruction with two classes. These models were used as reference for a heterogenous refinement with no symmetry imposed. The best class from heterogenous refinement which contained 2,415,222 particles were subjected to non-uniform 3D refinements, followed by local 3D refinements, yielding final CLC2-TM map at 2.46 Å, as determined by the gold-standard measure of Fourier shell correlation (FSC) using a cut-off of 0.143. Local resolution was estimated with relion 3.1. To further improve density map of CTD, the selected 2,415,222 particles were divided into 10 subsets for 3D classification in relion 3.1. A reference map for 3D classification was generated by the 3D ab initio model in CryoSparc. Two of the classes, containing 56,580 and 39,272 particles respectively, showed distinct CTD features and were used for further non-uniform 3D refinement and local 3D refinements, separately. The resolution was determined by Fourier shell correlation (FSC) using a cut-off of 0.143 at 2.75 Å and 2.76 Å, respectively.</p>
<p>Processing for CLC2-AK42 sample was executed similarly as described above. In brief, a total of 14,300 movie stacks were motion corrected by CryoSPARC. After auto-picking, 5,214,695 particles were extracted and subjected to 2D classification. After 2D classification, 2,391,813 particles were used for non-uniform 3D and local refinement to generate the final 2.74 Å map. To further improve the CTD density map, 3D classification was performed. The best of the 10 classes, containing 66,251 particles, was used for further refinement. Local refinement with masking of the CTD allowed a resolution 4.03 Å to be reached.</p>
</sec>
<sec id="s4d">
<title>Model building and refinement</title>
<p>The initial model of CLC-2 was generated by SWISS-MODEL using human CLC-1 (PDB:6qvc) as a homology model. It was fit to each map and manually rebuilt using Coot (<xref ref-type="bibr" rid="c27">Emsley and Cowtan, 2004</xref>) (v0.91). The models were further refined with ISOLDE (<xref ref-type="bibr" rid="c18">Croll, 2018</xref>) in ChimeraX (<xref ref-type="bibr" rid="c75">Pettersen et al., 2004</xref>) (v.1.6) and Phenix (<xref ref-type="bibr" rid="c54">Liebschner et al., 2019</xref>) (v1.20) real space refinement. The two potential conformations for the AK-42 ligand were tested using the Quantum Mechanical Restraints (QMR) method (<xref ref-type="bibr" rid="c55">Liebschner et al., 2023</xref>). Q-scores were performed with the MapQ Chimera plugin v1.9.12.</p>
</sec>
<sec id="s4e">
<title>Cell surface protein biotinylation and isolation</title>
<p>CHO K1 cells (ATCC CCL–61) were cultured at 37°C [95/5% O<sub>2</sub>/CO<sub>2</sub> ratio] in F12K media (ATCC, Catalog no. 30-2004) supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco). Cells were seeded at 5×10<sup>6</sup> in 15-cm dishes. After 48 hours, the confluency reached around 60%, and cells were transfected with 6 µg of CLC-2 plasmid, either WT or Delta-N, using Lipofectamine LTX, opti-MEM, and PLUS reagent (Invitrogen). For the control sample, CHO cells were seeded at the same time as the transfected groups and kept culturing in parallel. 48-72 hours after transient transfection, two 15-cm dishes cells for each sample (WT, Delta-N, or control) were combined to create one sample for use in the biotinylation of surface proteins assay, which was performed using a Pierce cell surface protein biotinylation and isolation kit (Thermo Scientific, A44390). Briefly, cells were washed twice in PBS (0.1 M sodium phosphate, 0.15 M NaCl, pH 7.2) and then incubated with PBS containing 0.25 mg/ml of sulfosuccinimidyl 2-(biotin-amido)-ethyl-1,3-dithiopropionate (EZ-link Sulfo-NHS-SS-biotin, Pierce) at room temperature for 10 minutes. Cells were incubated in ice-cold TBS (25 mM Tris, 0.15 M NaCl, pH 7.2) twice to quench the labeling. Cells were then scraped and lysed in lysis buffer from the Kit. Samples were incubated at 4°C for 30 minutes and then centrifugated at 15,000 × g for 5 minutes. Following centrifugation, the extracted membrane samples from the supernatant were incubated with 50 µl NeutrAvidin™ Agarose (Pierce) at 4°C for 2 hours, then washed with wash buffer from the kit four times. Finally, the isolated proteins were eluted with 60 μl elution buffer (from the kit) containing 100 mM DTT. 40 μl of each sample was used for Western blotting detection with 1:2,500 anti-GFP antibody (Invitrogen A11122) and 1:10,000 anti-rabbit secondary antibody (Licor 926-68073). The relative expression level was calculated by quantifying the intensities of the 100-kD bands on the Western blot, using a Li-Cor Odyssey 9120 Infrared Imaging System. The samples from three independent experiments (independent transfections on different days) were run on a single Western blot, shown in <xref rid="fig6" ref-type="fig">Figure 6C</xref>.</p>
</sec>
<sec id="s4f">
<title>Cell Culture and patch-clamp recording</title>
<p>CHO K1 cells (ATCC CCL–61) were cultured at 37°C [95/5% O2/CO2 ratio] in F12K media (ATCC, Catalog no. 30-2004) supplemented with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin (Gibco). At 60% confluency, cells were transfected with 120 ng CLC-2, either WT or Delta-N, using Lipofectamine LTX, opti-MEM, and PLUS reagent (Invitrogen). 105 ng of a soluble GFP construct was co-transfected with the CLC-2 construct to improve visualization of transfected cells.</p>
<p>Whole-cell patch-clamp experiments were performed using an Axopatch 200B amplifier attached to a Digidata 1440A. Data were acquired at 10 kHz with filtering at 5 kHz. Traces shown in figures were filtered offline in Clampfit at 1 kHz (8-pole Bessel). Borosilicate glass micropipettes (Sutter Instruments BF150-86-10) were pulled and fire-polished to a tip diameter with a resistance of 1.8 to 3.4 MΩ. For whole-cell patch-clamp recordings, the external solution was composed of 148 mM CsCl, 2 mM CaCl<sub>2</sub> (from a 1 M aqueous stock), 100 mM D-mannitol, and 10 mM HEPES, adjusted to pH 7.4 with 2 M CsOH. The internal solution was composed of 146 mM CsCl, 5 mM EGTA, 5 mM NaF, 60 mM D-mannitol, and 10 mM HEPES, adjusted to pH 7.4 with 2 M CsOH. Bath perfusion of external solution (2 mL/min) was initiated after whole cell and series resistance compensation (70% or more) was established. For leak subtraction, 300 nM AK-42 was perfused at 2 mL/min. AK-42 was diluted from a 1 mM stock solution in DMSO (0.03% final [DMSO]).</p>
</sec>
<sec id="s4g">
<title>MD simulations</title>
<sec id="s4g1">
<title>System setup for MD simultions</title>
<p>The apo dimer structure was used for simulations. For all simulations, hydrogen atoms were added, and protein chain termini were capped with neutral acetyl and methylamide groups. Titratable residues were kept in their dominant protonation state at pH 7. Histidine residues were modeled as neutral, with a hydrogen atom bound to epsilon nitrogen. The Dowser program was used to hydrate pockets within and around each structure (<xref ref-type="bibr" rid="c63">Morozenko and Stuchebrukhov, 2016</xref>). Then the receptor was inserted into a pre-equilibrated palmitoyl-oleoyl-phosphatidylcholine (POPC) bilayer using Dabble (<xref ref-type="bibr" rid="c9">Betz, 2017</xref>). Sodium and chloride ions were added to neutralize each system at a concentration of 150 mM. Approximate system dimensions were 131 Å x 95 Å x 125 Å.</p>
</sec>
<sec id="s4g2">
<title>Simulation protocols</title>
<p>All simulations were run on a single Graphical Processing Unit (GPU) using the Amber18 Compute Unified Device Architecture (CUDA) version of particle-mesh Ewald molecular dynamics (PMEMD) (<xref ref-type="bibr" rid="c81">Salomon-Ferrer et al., 2013</xref>). We used the CHARMM36m parameter set for protein molecules, lipids, and ions, and the CHARMM TIP3P water model for waters (<xref ref-type="bibr" rid="c44">Huang and MacKerell, 2013</xref>). Heating (to 310 K over 137.5 ps) and equilibration (28 ns with restraints on protein and ligand) steps were performed before production simulations as described previously (<xref ref-type="bibr" rid="c91">Suomivuori et al., 2020</xref>). Trajectory snapshots were saved every 200 ps. All simulations were at least 2 microseconds in length.</p>
</sec>
<sec id="s4g3">
<title>Simulation analysis protocols</title>
<p>The AmberTools18 CPPTRAJ package (<xref ref-type="bibr" rid="c79">Roe and Cheatham, 2013</xref>) was used to reimage trajectories, while Visual Molecular Dynamics (VMD) (<xref ref-type="bibr" rid="c45">Humphrey et al., 1996</xref>), PyMol (Schrodinger), and Matplotlib Python package were used for visualization and analysis. For analysis, the N-terminus peptide backbone was defined as segment name P5, excluding residues 14 15 27 28. For the CTD analysis, we used segment names P9 P3 P4 P8 excluding residue 419 to 578. For bar plots, individual dots show the average value in each independent simulation. Bar values show the average value across the independent simulations. The error bars for simulation results show the 68% confidence intervals of the mean (appropriate for non-parametric distributions) calculated using bootstrapping with the Seaborn Python library.</p>
</sec>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Huawei Zhang for sharing pdb coordinates and cryo-EM density for CLC-2/AK-42 in advance of release. We thank Anna Koster, Bill Kobertz, Dan Collins, Jürgen Kreiter, Martin Prieto, Shwetha Srinivasan, and Chris Miller for comments on the manuscript. We also thank Nigel Moriarty (Phenix) for performing Quantum Mechanical Restraints (QMR) analysis of the AK-42 ligand. This research was funded by NIH R21NS125767 (M.M. and W.C.) and NIH R01NS113611 (M.M., J.D.B., and R.O.D.). CryoEM was performed at the Stanford-SLAC Cryo-EM Center (S<sup>2</sup>C<sup>2</sup>), which is supported by the National Institutes of Health Common Fund Transformative High-Resolution Cryo-Electron Microscopy program (U24 GM129541). M.X. is supported by a Wu Tsai Neurosciences Institute Interdisciplinary Scholar Award. S.D.M. is supported by a Stanford Bio-X Bowes fellowship.</p>
</ack>
<sec id="s5">
<title>Data availability</title>
<p>Cryo-EM Density maps and structure coordinates have been deposited in the Electron Microscopy Data Bank (EMDB) and the Protein Data Bank (PDB), with accession codes EMD-41127 and PDB 8TA3 for the CLC2-TM, EMD-41128 and PDB 8TA4 for the CLC2-CTDsym, EMD-41129 and PDB 8TA5 for CLC2-CTDasym, EMD-41126 and PDB 8TA2 for CLC2-TM-AK42, and EMD-41130 and PDB 8TA6 for CLC2-AK42-CTD-only.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Accardi</surname>, <given-names>A</given-names></string-name>. <year>2015</year>. <article-title>Structure and gating of CLC channels and exchangers</article-title>. <source>J. Physiol</source>. <volume>593</volume>:<fpage>4129</fpage>–<lpage>4138</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Accardi</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>C.</given-names> <surname>Miller</surname></string-name>. <year>2004</year>. <article-title>Secondary active transport mediated by a prokaryotic homologue of ClC Cl-channels</article-title>. <source>Nature</source>. <volume>427</volume>:<fpage>803</fpage>–<lpage>807</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Ahmed</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Ramjeesingh</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Varga</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Garami</surname></string-name>, and <string-name><given-names>C.E.</given-names> <surname>Bear</surname></string-name>. <year>2000</year>. <article-title>Chloride channel activity of ClC-2 is modified by the actin cytoskeleton</article-title>. <source>Biochem. J</source>. <volume>352</volume> <issue>Pt 3</issue>:<fpage>789</fpage>–<lpage>794</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Alioth</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Meyer</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Dutzler</surname></string-name>, and <string-name><given-names>K.</given-names> <surname>Pervushin</surname></string-name>. <year>2007</year>. <article-title>The cytoplasmic domain of the chloride channel ClC-0: structural and dynamic characterization of flexible regions</article-title>. <source>J. Mol. Biol</source>. <volume>369</volume>:<fpage>1163</fpage>–<lpage>1169</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Altamura</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>J.F.</given-names> <surname>Desaphy</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Conte</surname></string-name>, <string-name><given-names>A.</given-names> <surname>De Luca</surname></string-name>, and <string-name><given-names>P.</given-names> <surname>Imbrici</surname></string-name>. <year>2020</year>. <article-title>Skeletal muscle ClC-1 chloride channels in health and diseases</article-title>. <source>Pflugers Arch</source>. <volume>472</volume>:<fpage>961</fpage>–<lpage>975</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Anashkin</surname>, <given-names>V.A.</given-names></string-name>, <string-name><given-names>A.A.</given-names> <surname>Baykov</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>Lahti</surname></string-name>. <year>2017</year>. <article-title>Enzymes Regulated via Cystathionine beta-Synthase Domains</article-title>. <source>Biochemistry (Mosc.)</source>. <volume>82</volume>:<fpage>1079</fpage>–<lpage>1087</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Arreola</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Begenisich</surname></string-name>, and <string-name><given-names>J.E.</given-names> <surname>Melvin</surname></string-name>. <year>2002</year>. <article-title>Conformation-dependent regulation of inward rectifier chloride channel gating by extracellular protons</article-title>. <source>J. Physiol</source>. <volume>541</volume>:<fpage>103</fpage>–<lpage>112</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Arreola</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>J.A.</given-names> <surname>De Santiago-Castillo</surname></string-name>, <string-name><given-names>J.E.</given-names> <surname>Sanchez</surname></string-name>, and <string-name><given-names>P.G.</given-names> <surname>Nieto</surname></string-name>. <year>2008</year>. <article-title>Gating and trafficking of ClC-2 chloride channel without cystathionine beta-synthase domains</article-title>. <source>J. Physiol</source>. <volume>586</volume>:<fpage>5289</fpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Betz</surname>, <given-names>R.M.</given-names></string-name> <year>2017</year>. <article-title>v2.6.3</article-title>. <source>Zenodo</source>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Bosl</surname>, <given-names>M.R.</given-names></string-name>, <string-name><given-names>V.</given-names> <surname>Stein</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Hubner</surname></string-name>, <string-name><given-names>A.A.</given-names> <surname>Zdebik</surname></string-name>, <string-name><given-names>S.E.</given-names> <surname>Jordt</surname></string-name>, <string-name><given-names>A.K.</given-names> <surname>Mukhopadhyay</surname></string-name>, <string-name><given-names>M.S.</given-names> <surname>Davidoff</surname></string-name>, <string-name><given-names>A.F.</given-names> <surname>Holstein</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>2001</year>. <article-title>Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(-) channel disruption</article-title>. <source>EMBO J</source>. <volume>20</volume>:<fpage>1289</fpage>–<lpage>1299</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Bykova</surname>, <given-names>E.A.</given-names></string-name>, <string-name><given-names>X.D.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>T.Y.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Zheng</surname></string-name>. <year>2006</year>. <article-title>Large movement in the C terminus of CLC-0 chloride channel during slow gating</article-title>. <source>Nat. Struct. Mol. Biol</source>. <volume>13</volume>:<fpage>1115</fpage>–<lpage>1119</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Cederholm</surname>, <given-names>J.M.</given-names></string-name>, <string-name><given-names>G.Y.</given-names> <surname>Rychkov</surname></string-name>, <string-name><given-names>C.J.</given-names> <surname>Bagley</surname></string-name>, and <string-name><given-names>A.H.</given-names> <surname>Bretag</surname></string-name>. <year>2010</year>. <article-title>Inter-subunit communication and fast gate integrity are important for common gating in hClC-1</article-title>. <source>Int. J. Biochem. Cell Biol</source>. <volume>42</volume>:<fpage>1182</fpage>–<lpage>1188</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Chavan</surname>, <given-names>T.S.</given-names></string-name>, <string-name><given-names>R.C.</given-names> <surname>Cheng</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jiang</surname></string-name>, <string-name><surname>Mathews</surname>, <given-names>II</given-names></string-name>, <string-name><given-names>R.A.</given-names> <surname>Stein</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Koehl</surname></string-name>, <string-name><given-names>H.S.</given-names> <surname>McHaourab</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Tajkhorshid</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Maduke</surname></string-name>. <year>2020</year>. <article-title>A CLC-ec1 mutant reveals global conformational change and suggests a unifying mechanism for the CLC Cl(-)/H(+) transport cycle</article-title>. <source>Elife</source>. <volume>9</volume>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>T.Y</given-names></string-name>. <year>1998</year>. <article-title>Extracellular zinc ion inhibits ClC-0 chloride channels by facilitating slow gating</article-title>. <source>J. Gen. Physiol</source>. <volume>112</volume>:<fpage>715</fpage>–<lpage>726</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>T.Y</given-names></string-name>. <year>2005</year>. <article-title>Structure and function of clc channels</article-title>. <source>Annu. Rev. Physiol</source>. <volume>67</volume>:<fpage>809</fpage>–<lpage>839</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Chovancova</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Pavelka</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Benes</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Strnad</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Brezovsky</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Kozlikova</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Gora</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Sustr</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Klvana</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Medek</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Biedermannova</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Sochor</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Damborsky</surname></string-name>. <year>2012</year>. <article-title>CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures</article-title>. <source>PLoS Comput. Biol</source>. <volume>8</volume>:<fpage>e1002708</fpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Cid</surname>, <given-names>L.P.</given-names></string-name>, <string-name><given-names>M.I.</given-names> <surname>Niemeyer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Ramirez</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2000</year>. <article-title>Splice variants of a ClC-2 chloride channel with differing functional characteristics</article-title>. <source>Am. J. Physiol. Cell Physiol</source>. <volume>279</volume>:<fpage>C1198</fpage>–<lpage>1210</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Croll</surname>, <given-names>T.I</given-names></string-name>. <year>2018</year>. <article-title>ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps</article-title>. <source>Acta Crystallogr D Struct Biol</source>. <volume>74</volume>:<fpage>519</fpage>–<lpage>530</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>De Jesus-Perez</surname>, <given-names>J.J.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Castro-Chong</surname></string-name>, <string-name><given-names>R.C.</given-names> <surname>Shieh</surname></string-name>, <string-name><given-names>C.Y.</given-names> <surname>Hernandez-Carballo</surname></string-name>, <string-name><given-names>J.A.</given-names> <surname>De Santiago-Castillo</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>. <year>2016</year>. <article-title>Gating the glutamate gate of CLC-2 chloride channel by pore occupancy</article-title>. <source>J. Gen. Physiol</source>. <volume>147</volume>:<fpage>25</fpage>–<lpage>37</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>De Jesus-Perez</surname>, <given-names>J.J.</given-names></string-name>, <string-name><given-names>G.A.</given-names> <surname>Mendez-Maldonado</surname></string-name>, <string-name><given-names>A.E.</given-names> <surname>Lopez-Romero</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Esparza-Jasso</surname></string-name>, <string-name><given-names>I.L.</given-names> <surname>Gonzalez-Hernandez</surname></string-name>, <string-name><given-names>V.</given-names> <surname>De la Rosa</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Gastelum-Garibaldi</surname></string-name>, <string-name><given-names>J.E.</given-names> <surname>Sanchez-Rodriguez</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>. <year>2021</year>. <article-title>Electro-steric opening of the CLC-2 chloride channel gate</article-title>. <source>Sci Rep</source>. <volume>11</volume>:<fpage>13127</fpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>de Santiago</surname>, <given-names>J.A.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Nehrke</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>. <year>2005</year>. <article-title>Quantitative analysis of the voltage-dependent gating of mouse parotid ClC-2 chloride channel</article-title>. <source>J. Gen. Physiol</source>. <volume>126</volume>:<fpage>591</fpage>–<lpage>603</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Duan</surname>, <given-names>D.D</given-names></string-name>. <year>2013</year>. <article-title>Phenomics of cardiac chloride channels</article-title>. <source>Compr Physiol</source>. <volume>3</volume>:<fpage>667</fpage>–<lpage>692</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Duffield</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Rychkov</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bretag</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Roberts</surname></string-name>. <year>2003</year>. <article-title>Involvement of Helices at the Dimer Interface in ClC-1 Common Gating</article-title>. <source>J. Gen. Physiol</source>. <volume>121</volume>:<fpage>149</fpage>–<lpage>161</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Duncan</surname>, <given-names>A.R.</given-names></string-name>, <string-name><given-names>M.M.</given-names> <surname>Polovitskaya</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Gaitan-Penas</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Bertelli</surname></string-name>, <string-name><given-names>G.E.</given-names> <surname>VanNoy</surname></string-name>, <string-name><given-names>P.E.</given-names> <surname>Grant</surname></string-name>, <string-name><given-names>A.</given-names> <surname>O’Donnell-Luria</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Valivullah</surname></string-name>, <string-name><given-names>A.K.</given-names> <surname>Lovgren</surname></string-name>, <string-name><given-names>E.M.</given-names> <surname>England</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Agolini</surname></string-name>, <string-name><given-names>J.A.</given-names> <surname>Madden</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Schmitz-Abe</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kritzer</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Hawley</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Novelli</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Alfieri</surname></string-name>, <string-name><given-names>G.S.</given-names> <surname>Colafati</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Wieczorek</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Platzer</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Luppe</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Koch-Hogrebe</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Abou Jamra</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Neira-Fresneda</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Lehman</surname></string-name>, <string-name><given-names>C.F.</given-names> <surname>Boerkoel</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Seath</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Clarke</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Study</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>van Ierland</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Argilli</surname></string-name>, <string-name><given-names>E.H.</given-names> <surname>Sherr</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Maiorana</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Diel</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Hempel</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Bierhals</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Estevez</surname></string-name>, <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, and <string-name><given-names>P.B.</given-names> <surname>Agrawal</surname></string-name>. <year>2021</year>. <article-title>Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders</article-title>. <source>Am. J. Hum. Genet</source>. <volume>108</volume>:<fpage>1450</fpage>–<lpage>1465</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Dutzler</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>E.B.</given-names> <surname>Campbell</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Cadene</surname></string-name>, <string-name><given-names>B.T.</given-names> <surname>Chait</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2002</year>. <article-title>X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity</article-title>. <source>Nature</source>. <volume>415</volume>:<fpage>287</fpage>–<lpage>294</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Dutzler</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>E.B.</given-names> <surname>Campbell</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2003</year>. <article-title>Gating the selectivity filter in ClC chloride channels</article-title>. <source>Science</source>. <volume>300</volume>:<fpage>108</fpage>–<lpage>112</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Emsley</surname>, <given-names>P.</given-names></string-name>, and <string-name><given-names>K.</given-names> <surname>Cowtan</surname></string-name>. <year>2004</year>. <article-title>Coot: model-building tools for molecular graphics</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>60</volume>:<fpage>2126</fpage>–<lpage>2132</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Ereno-Orbea</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>I.</given-names> <surname>Oyenarte</surname></string-name>, and <string-name><given-names>L.A.</given-names> <surname>Martinez-Cruz</surname></string-name>. <year>2013</year>. <article-title>CBS domains: Ligand binding sites and conformational variability</article-title>. <source>Arch. Biochem. Biophys</source>. <volume>540</volume>:<fpage>70</fpage>–<lpage>81</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Estevez</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ferrer-Costa</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Orozco</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>2004</year>. <article-title>Functional and structural conservation of CBS domains from CLC chloride channels</article-title>. <source>J. Physiol</source>. <volume>557</volume>:<fpage>363</fpage>–<lpage>378</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Feng</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>E.B.</given-names> <surname>Campbell</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Hsiung</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2010</year>. <article-title>Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle</article-title>. <source>Science</source>. <volume>330</volume>:<fpage>635</fpage>–<lpage>641</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Feng</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>E.B.</given-names> <surname>Campbell</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2012</year>. <article-title>Molecular mechanism of proton transport in CLC Cl-/H+ exchange transporters</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>109</volume>:<fpage>11699</fpage>–<lpage>11704</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Fernandes-Rosa</surname>, <given-names>F.L.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Daniil</surname></string-name>, <string-name><given-names>I.J.</given-names> <surname>Orozco</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Goppner</surname></string-name>, <string-name><given-names>R.</given-names> <surname>El Zein</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Jain</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Boulkroun</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Jeunemaitre</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Amar</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lefebvre</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Schwarzmayr</surname></string-name>, <string-name><given-names>T.M.</given-names> <surname>Strom</surname></string-name>, <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>, and <string-name><given-names>M.C.</given-names> <surname>Zennaro</surname></string-name>. <year>2018</year>. <article-title>A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism</article-title>. <source>Nat. Genet</source>. <volume>50</volume>:<fpage>355</fpage>–<lpage>361</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Furukawa</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Horikawa</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Terai</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ogura</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Katayama</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Hiraoka</surname></string-name>. <year>1995</year>. <article-title>Molecular cloning and characterization of a novel truncated from (ClC-2 beta) of ClC-2 alpha (ClC-2G) in rabbit heart</article-title>. <source>FEBS. Lett</source>. <volume>375</volume>:<fpage>56</fpage>–<lpage>62</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Gaitan-Penas</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>P.M.</given-names> <surname>Apaja</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Arnedo</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Castellanos</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Elorza-Vidal</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Soto</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Gasull</surname></string-name>, <string-name><given-names>G.L.</given-names> <surname>Lukacs</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>Estevez</surname></string-name>. <year>2017</year>. <article-title>Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl(-) channel function and trafficking</article-title>. <source>J. Physiol</source>. <volume>595</volume>:<fpage>6993</fpage>–<lpage>7008</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Garcia-Olivares</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Alekov</surname></string-name>, <string-name><given-names>M.R.</given-names> <surname>Boroumand</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Begemann</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Hidalgo</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>. <year>2008</year>. <article-title>Gating of human ClC-2 chloride channels and regulation by carboxy-terminal domains</article-title>. <source>J. Physiol</source>. <volume>586</volume>:<fpage>5325</fpage>–<lpage>5336</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Gianesello</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Del Prete</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ceol</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Priante</surname></string-name>, <string-name><given-names>L.A.</given-names> <surname>Calo</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Anglani</surname></string-name>. <year>2020</year>. <article-title>From protein uptake to Dent disease: An overview of the CLCN5 gene</article-title>. <source>Gene</source>. <volume>747</volume>:<fpage>144662</fpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Giorgio</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Vaula</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Benna</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Lo Buono</surname></string-name>, <string-name><given-names>C.M.</given-names> <surname>Eandi</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Dino</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Mancini</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Cavalieri</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Di Gregorio</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Pozzi</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ferrero</surname></string-name>, <string-name><given-names>M.T.</given-names> <surname>Giordana</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Depienne</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Brusco</surname></string-name>. <year>2017</year>. <article-title>A novel homozygous change of CLCN2 (p.His590Pro) is associated with a subclinical form of leukoencephalopathy with ataxia (LKPAT)</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source>. <volume>88</volume>:<fpage>894</fpage>–<lpage>896</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Goehring</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>C.H.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>K.H.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>J.C.</given-names> <surname>Michel</surname></string-name>, <string-name><given-names>D.P.</given-names> <surname>Claxton</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Baconguis</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Althoff</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Fischer</surname></string-name>, <string-name><given-names>K.C.</given-names> <surname>Garcia</surname></string-name>, and <string-name><given-names>E.</given-names> <surname>Gouaux</surname></string-name>. <year>2014</year>. <article-title>Screening and large-scale expression of membrane proteins in mammalian cells for structural studies</article-title>. <source>Nat. Protoc</source>. <volume>9</volume>:<fpage>2574</fpage>–<lpage>2585</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Goppner</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>I.J.</given-names> <surname>Orozco</surname></string-name>, <string-name><given-names>M.B.</given-names> <surname>Hoegg-Beiler</surname></string-name>, <string-name><given-names>A.H.</given-names> <surname>Soria</surname></string-name>, <string-name><given-names>C.A.</given-names> <surname>Hubner</surname></string-name>, <string-name><given-names>F.L.</given-names> <surname>Fernandes-Rosa</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Boulkroun</surname></string-name>, <string-name><given-names>M.C.</given-names> <surname>Zennaro</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>2019</year>. <article-title>Pathogenesis of hypertension in a mouse model for human CLCN2 related hyperaldosteronism</article-title>. <source>Nat. Commun</source>. <volume>10</volume>:<fpage>4678</fpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Grieschat</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>R.E.</given-names> <surname>Guzman</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Langschwager</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>, and <string-name><given-names>A.K.</given-names> <surname>Alekov</surname></string-name>. <year>2020</year>. <article-title>Metabolic energy sensing by mammalian CLC anion/proton exchangers</article-title>. <source>EMBO Rep</source>. <volume>21</volume>:<fpage>e47872</fpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Grunder</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Thiemann</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1992</year>. <article-title>Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume</article-title>. <source>Nature</source>. <volume>360</volume>:<fpage>759</fpage>–<lpage>762</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Guo</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Cheng</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>W.</given-names> <surname>Qiu</surname></string-name>. <year>2019</year>. <article-title>CLCN2-related leukoencephalopathy: a case report and review of the literature</article-title>. <source>BMC Neurol</source>. <volume>19</volume>:<fpage>156</fpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Hansen</surname>, <given-names>T.H.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Yan</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Ahlberg</surname></string-name>, <string-name><given-names>O.B.</given-names> <surname>Vad</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Refsgaard</surname></string-name>, <string-name><given-names>J.L.</given-names> <surname>Dos Santos</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Mutsaers</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Svendsen</surname></string-name>, <string-name><given-names>M.S.</given-names> <surname>Olesen</surname></string-name>, <string-name><given-names>B.H.</given-names> <surname>Bentzen</surname></string-name>, and <string-name><given-names>N.</given-names> <surname>Schmitt</surname></string-name>. <year>2020</year>. <article-title>A Novel Loss-of-Function Variant in the Chloride Ion Channel Gene Clcn2 Associates with Atrial Fibrillation</article-title>. <source>Sci Rep</source>. <volume>10</volume>:<fpage>1453</fpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>, <given-names>J.</given-names></string-name>, and <string-name><given-names>A.D.</given-names> <surname>MacKerell</surname>, <suffix>Jr</suffix></string-name>. <year>2013</year>. <article-title>CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data</article-title>. <source>J Comput Chem</source>. <volume>34</volume>:<fpage>2135</fpage>–<lpage>2145</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Humphrey</surname>, <given-names>W.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Dalke</surname></string-name>, and <string-name><given-names>K.</given-names> <surname>Schulten</surname></string-name>. <year>1996</year>. <article-title>VMD: visual molecular dynamics</article-title>. <source>J. Mol. Graph</source>. <volume>14</volume>:<fpage>33</fpage>–<lpage>38</lpage>, 27-38.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Jardetzky</surname>, <given-names>O</given-names></string-name>. <year>1966</year>. <article-title>Simple allosteric model for membrane pumps</article-title>. <source>Nature</source>. <volume>211</volume>:<fpage>969</fpage>–<lpage>970</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Jentsch</surname>, <given-names>T.J.</given-names></string-name>, and <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>. <year>2018</year>. <article-title>CLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease</article-title>. <source>Physiol. Rev</source>. <volume>98</volume>:<fpage>1493</fpage>–<lpage>1590</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Jeworutzki</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Lopez-Hernandez</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Capdevila-Nortes</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Sirisi</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Bengtsson</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Montolio</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Zifarelli</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Arnedo</surname></string-name>, <string-name><given-names>C.S.</given-names> <surname>Muller</surname></string-name>, <string-name><given-names>U.</given-names> <surname>Schulte</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Nunes</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Martinez</surname></string-name>, <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Gasull</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>Estevez</surname></string-name>. <year>2012</year>. <article-title>GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a ClC-2 Cl(-) Channel Auxiliary Subunit</article-title>. <source>Neuron</source>. <volume>73</volume>:<fpage>951</fpage>–<lpage>961</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Jordt</surname>, <given-names>S.E.</given-names></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1997</year>. <article-title>Molecular dissection of gating in the ClC-2 chloride channel</article-title>. <source>EMBO J</source>. <volume>16</volume>:<fpage>1582</fpage>–<lpage>1592</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Kieferle</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>P.</given-names> <surname>Fong</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bens</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Vandewalle</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1994</year>. <article-title>Two highly homologous members of the ClC chloride channel family in both rat and human kidney</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>91</volume>:<fpage>6943</fpage>–<lpage>6947</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Koster</surname>, <given-names>A.K.</given-names></string-name>, <string-name><given-names>A.L.</given-names> <surname>Reese</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kuryshev</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Wen</surname></string-name>, <string-name><given-names>K.A.</given-names> <surname>McKiernan</surname></string-name>, <string-name><given-names>E.E.</given-names> <surname>Gray</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>J.R.</given-names> <surname>Huguenard</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Maduke</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Du Bois</surname></string-name>. <year>2020</year>. <article-title>Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Lein</surname>, <given-names>E.S.</given-names></string-name>, <string-name><given-names>M.J.</given-names> <surname>Hawrylycz</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Ao</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ayres</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bensinger</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bernard</surname></string-name>, <string-name><given-names>A.F.</given-names> <surname>Boe</surname></string-name>, <string-name><given-names>M.S.</given-names> <surname>Boguski</surname></string-name>, <string-name><given-names>K.S.</given-names> <surname>Brockway</surname></string-name>, <string-name><given-names>E.J.</given-names> <surname>Byrnes</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>T.M.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>M.C.</given-names> <surname>Chin</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chong</surname></string-name>, <string-name><given-names>B.E.</given-names> <surname>Crook</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Czaplinska</surname></string-name>, <string-name><given-names>C.N.</given-names> <surname>Dang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Datta</surname></string-name>, <string-name><given-names>N.R.</given-names> <surname>Dee</surname></string-name>, <string-name><given-names>A.L.</given-names> <surname>Desaki</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Desta</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Diep</surname></string-name>, <string-name><given-names>T.A.</given-names> <surname>Dolbeare</surname></string-name>, <string-name><given-names>M.J.</given-names> <surname>Donelan</surname></string-name>, <string-name><given-names>H.W.</given-names> <surname>Dong</surname></string-name>, <string-name><given-names>J.G.</given-names> <surname>Dougherty</surname></string-name>, <string-name><given-names>B.J.</given-names> <surname>Duncan</surname></string-name>, <string-name><given-names>A.J.</given-names> <surname>Ebbert</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Eichele</surname></string-name>, <string-name><given-names>L.K.</given-names> <surname>Estin</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Faber</surname></string-name>, <string-name><given-names>B.A.</given-names> <surname>Facer</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Fields</surname></string-name>, <string-name><given-names>S.R.</given-names> <surname>Fischer</surname></string-name>, <string-name><given-names>T.P.</given-names> <surname>Fliss</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Frensley</surname></string-name>, <string-name><given-names>S.N.</given-names> <surname>Gates</surname></string-name>, <string-name><given-names>K.J.</given-names> <surname>Glattfelder</surname></string-name>, <string-name><given-names>K.R.</given-names> <surname>Halverson</surname></string-name>, <string-name><given-names>M.R.</given-names> <surname>Hart</surname></string-name>, <string-name><given-names>J.G.</given-names> <surname>Hohmann</surname></string-name>, <string-name><given-names>M.P.</given-names> <surname>Howell</surname></string-name>, <string-name><given-names>D.P.</given-names> <surname>Jeung</surname></string-name>, <string-name><given-names>R.A.</given-names> <surname>Johnson</surname></string-name>, <string-name><given-names>P.T.</given-names> <surname>Karr</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Kawal</surname></string-name>, <string-name><given-names>J.M.</given-names> <surname>Kidney</surname></string-name>, <string-name><given-names>R.H.</given-names> <surname>Knapik</surname></string-name>, <string-name><given-names>C.L.</given-names> <surname>Kuan</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Lake</surname></string-name>, <string-name><given-names>A.R.</given-names> <surname>Laramee</surname></string-name>, <string-name><given-names>K.D.</given-names> <surname>Larsen</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>T.A.</given-names> <surname>Lemon</surname></string-name>, <string-name><given-names>A.J.</given-names> <surname>Liang</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>L.T.</given-names> <surname>Luong</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Michaels</surname></string-name>, <string-name><given-names>J.J.</given-names> <surname>Morgan</surname></string-name>, <string-name><given-names>R.J.</given-names> <surname>Morgan</surname></string-name>, <string-name><given-names>M.T.</given-names> <surname>Mortrud</surname></string-name>, <string-name><given-names>N.F.</given-names> <surname>Mosqueda</surname></string-name>, <string-name><given-names>L.L.</given-names> <surname>Ng</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Ng</surname></string-name>, <string-name><given-names>G.J.</given-names> <surname>Orta</surname></string-name>, <string-name><given-names>C.C.</given-names> <surname>Overly</surname></string-name>, <string-name><given-names>T.H.</given-names> <surname>Pak</surname></string-name>, <string-name><given-names>S.E.</given-names> <surname>Parry</surname></string-name>, <string-name><given-names>S.D.</given-names> <surname>Pathak</surname></string-name>, <string-name><given-names>O.C.</given-names> <surname>Pearson</surname></string-name>, <string-name><given-names>R.B.</given-names> <surname>Puchalski</surname></string-name>, <string-name><given-names>Z.L.</given-names> <surname>Riley</surname></string-name>, <string-name><given-names>H.R.</given-names> <surname>Rockett</surname></string-name>, <string-name><given-names>S.A.</given-names> <surname>Rowland</surname></string-name>, <string-name><given-names>J.J.</given-names> <surname>Royall</surname></string-name>, <string-name><given-names>M.J.</given-names> <surname>Ruiz</surname></string-name>, <string-name><given-names>N.R.</given-names> <surname>Sarno</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Schaffnit</surname></string-name>, <string-name><given-names>N.V.</given-names> <surname>Shapovalova</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sivisay</surname></string-name>, <string-name><given-names>C.R.</given-names> <surname>Slaughterbeck</surname></string-name>, <string-name><given-names>S.C.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>K.A.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>B.I.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>A.J.</given-names> <surname>Sodt</surname></string-name>, <string-name><given-names>N.N.</given-names> <surname>Stewart</surname></string-name>, <string-name><given-names>K.R.</given-names> <surname>Stumpf</surname></string-name>, <string-name><given-names>S.M.</given-names> <surname>Sunkin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sutram</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Tam</surname></string-name>, <string-name><given-names>C.D.</given-names> <surname>Teemer</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Thaller</surname></string-name>, <string-name><given-names>C.L.</given-names> <surname>Thompson</surname></string-name>, <string-name><given-names>L.R.</given-names> <surname>Varnam</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Visel</surname></string-name>, <string-name><given-names>R.M.</given-names> <surname>Whitlock</surname></string-name>, <string-name><given-names>P.E.</given-names> <surname>Wohnoutka</surname></string-name>, <string-name><given-names>C.K.</given-names> <surname>Wolkey</surname></string-name>, <string-name><given-names>V.Y.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Wood</surname></string-name>, <string-name><given-names>M.B.</given-names> <surname>Yaylaoglu</surname></string-name>, <string-name><given-names>R.C.</given-names> <surname>Young</surname></string-name>, <string-name><given-names>B.L.</given-names> <surname>Youngstrom</surname></string-name>, <string-name><given-names>X.F.</given-names> <surname>Yuan</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>T.A.</given-names> <surname>Zwingman</surname></string-name>, and <string-name><given-names>A.R.</given-names> <surname>Jones</surname></string-name>. <year>2007</year>. <article-title>Genome-wide atlas of gene expression in the adult mouse brain</article-title>. <source>Nature</source>. <volume>445</volume>:<fpage>168</fpage>–<lpage>176</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Leisle</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Fortea</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>J.D.</given-names> <surname>Galpin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Vien</surname></string-name>, <string-name><given-names>C.A.</given-names> <surname>Ahern</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Accardi</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Berneche</surname></string-name>. <year>2020</year>. <article-title>Divergent Cl(-) and H(+) pathways underlie transport coupling and gating in CLC exchangers and channels</article-title>. <source>Elife</source>. <volume>9</volume>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Liebschner</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>P.V.</given-names> <surname>Afonine</surname></string-name>, <string-name><given-names>M.L.</given-names> <surname>Baker</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bunkoczi</surname></string-name>, <string-name><given-names>V.B.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>T.I.</given-names> <surname>Croll</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Hintze</surname></string-name>, <string-name><given-names>L.W.</given-names> <surname>Hung</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Jain</surname></string-name>, <string-name><given-names>A.J.</given-names> <surname>McCoy</surname></string-name>, <string-name><given-names>N.W.</given-names> <surname>Moriarty</surname></string-name>, <string-name><given-names>R.D.</given-names> <surname>Oeffner</surname></string-name>, <string-name><given-names>B.K.</given-names> <surname>Poon</surname></string-name>, <string-name><given-names>M.G.</given-names> <surname>Prisant</surname></string-name>, <string-name><given-names>R.J.</given-names> <surname>Read</surname></string-name>, <string-name><given-names>J.S.</given-names> <surname>Richardson</surname></string-name>, <string-name><given-names>D.C.</given-names> <surname>Richardson</surname></string-name>, <string-name><given-names>M.D.</given-names> <surname>Sammito</surname></string-name>, <string-name><given-names>O.V.</given-names> <surname>Sobolev</surname></string-name>, <string-name><given-names>D.H.</given-names> <surname>Stockwell</surname></string-name>, <string-name><given-names>T.C.</given-names> <surname>Terwilliger</surname></string-name>, <string-name><given-names>A.G.</given-names> <surname>Urzhumtsev</surname></string-name>, <string-name><given-names>L.L.</given-names> <surname>Videau</surname></string-name>, <string-name><given-names>C.J.</given-names> <surname>Williams</surname></string-name>, and <string-name><given-names>P.D.</given-names> <surname>Adams</surname></string-name>. <year>2019</year>. <article-title>Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix</article-title>. <source>Acta Crystallogr D Struct Biol</source>. <volume>75</volume>:<fpage>861</fpage>–<lpage>877</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Liebschner</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>N.W.</given-names> <surname>Moriarty</surname></string-name>, <string-name><given-names>B.K.</given-names> <surname>Poon</surname></string-name>, and <string-name><given-names>P.D.</given-names> <surname>Adams</surname></string-name>. <year>2023</year>. <article-title>In situ ligand restraints from quantum-mechanical methods</article-title>. <source>Acta Crystallogr D Struct Biol</source>. <volume>79</volume>:<fpage>100</fpage>–<lpage>110</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Lisal</surname>, <given-names>J.</given-names></string-name>, and <string-name><given-names>M.</given-names> <surname>Maduke</surname></string-name>. <year>2008</year>. <article-title>The ClC-0 chloride channel is a ‘broken’ Cl-/H+ antiporter</article-title>. <source>Nat. Struct. Mol. Biol</source>. <volume>15</volume>:<fpage>805</fpage>–<lpage>810</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Ma</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>G.Y.</given-names> <surname>Rychkov</surname></string-name>, <string-name><given-names>E.A.</given-names> <surname>Bykova</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zheng</surname></string-name>, and <string-name><given-names>A.H.</given-names> <surname>Bretag</surname></string-name>. <year>2011</year>. <article-title>Movement of hClC-1 C-termini during common gating and limits on their cytoplasmic location</article-title>. <source>Biochem. J</source>. <volume>436</volume>:<fpage>415</fpage>–<lpage>428</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Ma</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Chai</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Cui</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yuan</surname></string-name>, <string-name><given-names>S. Wing</given-names> <surname>Ngor Au</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liang</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Vogel</surname></string-name>, <string-name><given-names>Y.T.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Yan</surname></string-name>, and <string-name><given-names>H.</given-names> <surname>Zhang</surname></string-name>. <year>2023</year>. <article-title>Cryo-EM structures of ClC-2 chloride channel reveal the blocking mechanism of its specific inhibitor AK-42</article-title>. <source>Nat. Commun</source>. <volume>14</volume>:<fpage>3424</fpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Maduke</surname>, <given-names>M.C.</given-names></string-name>, and <string-name><given-names>R.J.</given-names> <surname>Reimer</surname></string-name>. <year>2012</year>. <article-title>Biochemistry to the rescue: a ClC-2 auxiliary subunit provides a tangible link to leukodystrophy</article-title>. <source>Neuron</source>. <volume>73</volume>:<fpage>855</fpage>–<lpage>857</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>C</given-names></string-name>. <year>2006</year>. <article-title>ClC chloride channels viewed through a transporter lens</article-title>. <source>Nature</source>. <volume>440</volume>:<fpage>484</fpage>–<lpage>489</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>C</given-names></string-name>. <year>2014</year>. <article-title>In the beginning: A personal reminiscence on the origin and legacy of ClC-0, the “Torpedo Cl-channel”</article-title>. <source>J. Physiol</source>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Miller</surname>, <given-names>C</given-names></string-name>. <year>2021</year>. <article-title>Q-cubed mutant cues clues to CLC antiport mechanism</article-title>. <source>J. Gen. Physiol</source>. <volume>153</volume>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Morozenko</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>A.A.</given-names> <surname>Stuchebrukhov</surname></string-name>. <year>2016</year>. <article-title>Dowser++, a new method of hydrating protein structures</article-title>. <source>Proteins</source>. <volume>84</volume>:<fpage>1347</fpage>–<lpage>1357</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Nicoli</surname>, <given-names>E.R.</given-names></string-name>, <string-name><given-names>M.R.</given-names> <surname>Weston</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Hackbarth</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Becerril</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Larson</surname></string-name>, <string-name><given-names>W.M.</given-names> <surname>Zein</surname></string-name>, <string-name><given-names>P.R.</given-names> <surname>Baker</surname>, <suffix>2nd</suffix></string-name>, <string-name><given-names>J.D.</given-names> <surname>Burke</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Dorward</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Davids</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>D.R.</given-names> <surname>Adams</surname></string-name>, <string-name><given-names>P.M.</given-names> <surname>Zerfas</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>T.C.</given-names> <surname>Markello</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Toro</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Wood</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Elliott</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Vu</surname></string-name>, <collab>N. Undiagnosed Diseases</collab>, <string-name><given-names>W.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>L.J.</given-names> <surname>Garrett</surname></string-name>, <string-name><given-names>C.J.</given-names> <surname>Tifft</surname></string-name>, <string-name><given-names>W.A.</given-names> <surname>Gahl</surname></string-name>, <string-name><given-names>D.L.</given-names> <surname>Day-Salvatore</surname></string-name>, <string-name><given-names>J.A.</given-names> <surname>Mindell</surname></string-name>, and <string-name><given-names>M.C.V.</given-names> <surname>Malicdan</surname></string-name>. <year>2019</year>. <article-title>Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification</article-title>. <source>Am. J. Hum. Genet</source>. <volume>104</volume>:<fpage>1127</fpage>–<lpage>1138</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Niemeyer</surname>, <given-names>M.I.</given-names></string-name>, <string-name><given-names>L.P.</given-names> <surname>Cid</surname></string-name>, <string-name><given-names>Y.R.</given-names> <surname>Yusef</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Briones</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2009</year>. <article-title>Voltage-dependent and - independent titration of specific residues accounts for complex gating of a ClC chloride channel by extracellular protons</article-title>. <source>J. Physiol</source>. <volume>587</volume>:<fpage>1387</fpage>–<lpage>1400</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Niemeyer</surname>, <given-names>M.I.</given-names></string-name>, <string-name><given-names>L.P.</given-names> <surname>Cid</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Zuniga</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Catalan</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2003</year>. <article-title>A conserved pore-lining glutamate as a voltage- and chloride-dependent gate in the ClC-2 chloride channel</article-title>. <source>J. Physiol</source>. <volume>553</volume>:<fpage>873</fpage>–<lpage>879</lpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Nighot</surname>, <given-names>P.K.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Leung</surname></string-name>, and <string-name><given-names>T.Y.</given-names> <surname>Ma</surname></string-name>. <year>2017</year>. <article-title>Chloride channel ClC-2 enhances intestinal epithelial tight junction barrier function via regulation of caveolin-1 and caveolar trafficking of occludin</article-title>. <source>Exp. Cell Res</source>. <volume>352</volume>:<fpage>113</fpage>–<lpage>122</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Nishikawa</surname>, <given-names>K.O.</given-names></string-name>, <string-name><given-names>T.</given-names>; <surname>Isogai</surname></string-name>, <string-name><given-names>Y.</given-names>; <surname>Saitô</surname></string-name>, N. <year>1972</year>. <article-title>Tertiary Structure of Proteins</article-title>. <source>I. Representation and Computation of the Conformations. Journal of the physical society of Japan</source>. <volume>32</volume>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>Okamoto</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Nagasawa</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Obara</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ishii</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Takagi</surname></string-name>, and <string-name><given-names>K.</given-names> <surname>Ono</surname></string-name>. <year>2019</year>. <article-title>Molecular identification of HSPA8 as an accessory protein of a hyperpolarization-activated chloride channel from rat pulmonary vein cardiomyocytes</article-title>. <source>J. Biol. Chem</source>. <volume>294</volume>:<fpage>16049</fpage>–<lpage>16061</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>Palmer</surname>, <given-names>E.E.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Picollo</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Forwood</surname></string-name>, <string-name><given-names>M.H.</given-names> <surname>Nguyen</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Suckow</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Gibbons</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Hoff</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Sigfrid</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Megarbane</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Nizon</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Cogne</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Beneteau</surname></string-name>, <string-name><given-names>F.S.</given-names> <surname>Alkuraya</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Chedrawi</surname></string-name>, <string-name><given-names>M.O.</given-names> <surname>Hashem</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Stamberger</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Weckhuysen</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Vanlander</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Ceulemans</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Rajagopalan</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Nunn</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Arpin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Raynaud</surname></string-name>, <string-name><given-names>C.S.</given-names> <surname>Motter</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ward-Melver</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Janssens</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Meuwissen</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Beysen</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Dikow</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Grimmel</surname></string-name>, <string-name><given-names>T.B.</given-names> <surname>Haack</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Clement</surname></string-name>, <string-name><given-names>A.</given-names> <surname>McTague</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Hunt</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Townshend</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ward</surname></string-name>, <string-name><given-names>L.J.</given-names> <surname>Richards</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Simons</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Costain</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Dupuis</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Mendoza-Londono</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Dudding-Byth</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Boyle</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Saunders</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Fleming</surname></string-name>, <string-name><given-names>S.</given-names> <surname>El Chehadeh</surname></string-name>, <string-name><given-names>M.A.</given-names> <surname>Spitz</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Piton</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Gerard</surname></string-name>, <string-name><given-names>M.T.</given-names> <surname>Abi Warde</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Rea</surname></string-name>, <string-name><given-names>C.</given-names> <surname>McKenna</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Douzgou</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Banka</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Akman</surname></string-name>, <string-name><given-names>J.M.</given-names> <surname>Bain</surname></string-name>, <string-name><given-names>T.T.</given-names> <surname>Sands</surname></string-name>, <string-name><given-names>G.N.</given-names> <surname>Wilson</surname></string-name>, <string-name><given-names>E.J.</given-names> <surname>Silvertooth</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Miller</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Lederer</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Sachdev</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Macintosh</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Monestier</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Karadurmus</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Collins</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Carter</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Rohena</surname></string-name>, <string-name><given-names>M.H.</given-names> <surname>Willemsen</surname></string-name>, <string-name><given-names>C.W.</given-names> <surname>Ockeloen</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Pfundt</surname></string-name>, <string-name><given-names>S.D.</given-names> <surname>Kroft</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Field</surname></string-name>, <string-name><given-names>F.E.R.</given-names> <surname>Laranjeira</surname></string-name>, <string-name><given-names>A.M.</given-names> <surname>Fortuna</surname></string-name>, <string-name><given-names>A.R.</given-names> <surname>Soares</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Michaud</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Naudion</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Golla</surname></string-name>, <string-name><given-names>D.D.</given-names> <surname>Weaver</surname></string-name>, <string-name><given-names>L.M.</given-names> <surname>Bird</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Friedman</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Clowes</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Joss</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Polsler</surname></string-name>, <string-name><given-names>P.M.</given-names> <surname>Campeau</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Blazo</surname></string-name>, <string-name><given-names>E.K.</given-names> <surname>Bijlsma</surname></string-name>, <string-name><given-names>J.A.</given-names> <surname>Rosenfeld</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Beetz</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Powis</surname></string-name>, <string-name><given-names>K.</given-names> <surname>McWalter</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Brandt</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Torti</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mathot</surname></string-name>, <string-name><given-names>S.S.</given-names> <surname>Mohammad</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Armstrong</surname></string-name>, and <string-name><given-names>V.M.</given-names> <surname>Kalscheuer</surname></string-name>. <year>2023</year>. <article-title>Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition</article-title>. <source>Mol. Psychiatry</source>. <volume>28</volume>:<fpage>668</fpage>–<lpage>697</lpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Park</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>E.B.</given-names> <surname>Campbell</surname></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2017</year>. <article-title>Structure of a CLC chloride ion channel by cryo-electron microscopy</article-title>. <source>Nature</source>. <volume>541</volume>:<fpage>500</fpage>–<lpage>505</lpage>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Park</surname>, <given-names>E.</given-names></string-name>, and <string-name><given-names>R.</given-names> <surname>MacKinnon</surname></string-name>. <year>2018</year>. <article-title>Structure of the CLC-1 chloride channel from Homo sapiens</article-title>. <source>Elife</source>. <volume>7</volume>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Park</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Begenisich</surname></string-name>, and <string-name><given-names>J.E.</given-names> <surname>Melvin</surname></string-name>. <year>1998</year>. <article-title>Comparison of voltage-activated Cl-channels in rat parotid acinar cells with ClC-2 in a mammalian expression system</article-title>. <source>J. Membr. Biol</source>. <volume>163</volume>:<fpage>87</fpage>–<lpage>95</lpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Paul</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Jeyaraj</surname></string-name>, <string-name><given-names>S.M.</given-names> <surname>Huber</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Seebohm</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bohmer</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Lang</surname></string-name>, <string-name><given-names>P.G.</given-names> <surname>Kremsner</surname></string-name>, and <string-name><given-names>J.F.</given-names> <surname>Kun</surname></string-name>. <year>2007</year>. <article-title>Alterations in the cytoplasmic domain of CLCN2 result in altered gating kinetics</article-title>. <source>Cell. Physiol. Biochem</source>. <volume>20</volume>:<fpage>441</fpage>–<lpage>454</lpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><string-name><surname>Pettersen</surname>, <given-names>E.F.</given-names></string-name>, <string-name><given-names>T.D.</given-names> <surname>Goddard</surname></string-name>, <string-name><given-names>C.C.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>G.S.</given-names> <surname>Couch</surname></string-name>, <string-name><given-names>D.M.</given-names> <surname>Greenblatt</surname></string-name>, <string-name><given-names>E.C.</given-names> <surname>Meng</surname></string-name>, and <string-name><given-names>T.E.</given-names> <surname>Ferrin</surname></string-name>. <year>2004</year>. <article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title>. <source>J Comput Chem</source>. <volume>25</volume>:<fpage>1605</fpage>–<lpage>1612</lpage>.</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Pintilie</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>M.F.</given-names> <surname>Schmid</surname></string-name>, and <string-name><given-names>W.</given-names> <surname>Chiu</surname></string-name>. <year>2020</year>. <article-title>Measurement of atom resolvability in cryo-EM maps with Q-scores</article-title>. <source>Nat. Methods</source>. <volume>17</volume>:<fpage>328</fpage>–<lpage>334</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Pusch</surname>, <given-names>M</given-names></string-name>. <year>2002</year>. <article-title>Myotonia caused by mutations in the muscle chloride channel gene CLCN1</article-title>. <source>Hum. Mutat</source>. <volume>19</volume>:<fpage>423</fpage>–<lpage>434</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Pusch</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Jordt</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Stein</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1999</year>. <article-title>Chloride dependence of hyperpolarization-activated chloride channel gates</article-title>. <source>J. Physiol</source>. <volume>515</volume>:<fpage>341</fpage>–<lpage>353</lpage>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><string-name><surname>Roe</surname>, <given-names>D.R.</given-names></string-name>, and <string-name><given-names>T.E.</given-names> <surname>Cheatham</surname>, <suffix>3rd</suffix></string-name>. <year>2013</year>. <article-title>PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data</article-title>. <source>Journal of chemical theory and computation</source><volume>. 9</volume>:<fpage>3084</fpage>–<lpage>3095</lpage>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><string-name><surname>Saint-Martin</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Gauvain</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Teodorescu</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Gourfinkel-An</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Fedirko</surname></string-name>, <string-name><given-names>Y.G.</given-names> <surname>Weber</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Maljevic</surname></string-name>, <string-name><given-names>J.P.</given-names> <surname>Ernst</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Garcia-Olivares</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Nabbout</surname></string-name>, <string-name><given-names>E.</given-names> <surname>LeGuern</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lerche</surname></string-name>, <string-name><given-names>J.C.</given-names> <surname>Poncer</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Depienne</surname></string-name>. <year>2009</year>. <article-title>Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy</article-title>. <source>Hum. Mutat</source>. <volume>30</volume>:<fpage>397</fpage>–<lpage>405</lpage>.</mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><string-name><surname>Salomon-Ferrer</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>A.W.</given-names> <surname>Gotz</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Poole</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Le Grand</surname></string-name>, and <string-name><given-names>R.C.</given-names> <surname>Walker</surname></string-name>. <year>2013</year>. <article-title>Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald</article-title>. <source>Journal of chemical theory and computation</source>. <volume>9</volume>:<fpage>3878</fpage>–<lpage>3888</lpage>.</mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><string-name><surname>Sanchez-Rodriguez</surname>, <given-names>J.E.</given-names></string-name>, <string-name><given-names>J.A.</given-names> <surname>De Santiago-Castillo</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>. <year>2010</year>. <article-title>Permeant anions contribute to voltage dependence of ClC-2 chloride channel by interacting with the protopore gate</article-title>. <source>J. Physiol</source>. <volume>588</volume>:<fpage>2545</fpage>–<lpage>2556</lpage>.</mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><string-name><surname>Sanchez-Rodriguez</surname>, <given-names>J.E.</given-names></string-name>, <string-name><given-names>J.A.</given-names> <surname>De Santiago-Castillo</surname></string-name>, <string-name><given-names>J.A.</given-names> <surname>Contreras-Vite</surname></string-name>, <string-name><given-names>P.G.</given-names> <surname>Nieto-Delgado</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Castro-Chong</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Arreola</surname></string-name>. <year>2012</year>. <article-title>Sequential interaction of chloride and proton ions with the fast gate steer the voltage-dependent gating in ClC-2 chloride channels</article-title>. <source>J. Physiol</source>. <volume>590</volume>:<fpage>4239</fpage>–<lpage>4253</lpage>.</mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><string-name><surname>Scholl</surname>, <given-names>U.I.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Stolting</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Schewe</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Thiel</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Nelson-Williams</surname></string-name>, <string-name><given-names>A.A.</given-names> <surname>Vichot</surname></string-name>, <string-name><given-names>S.C.</given-names> <surname>Jin</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Loring</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Untiet</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Yoo</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Choi</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kirchner</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Mertins</surname></string-name>, <string-name><given-names>L.C.</given-names> <surname>Rump</surname></string-name>, <string-name><given-names>A.M.</given-names> <surname>Onder</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Gamble</surname></string-name>, <string-name><given-names>D.</given-names> <surname>McKenney</surname></string-name>, <string-name><given-names>R.W.</given-names> <surname>Lash</surname></string-name>, <string-name><given-names>D.P.</given-names> <surname>Jones</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Chune</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Gagliardi</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Choi</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Gordon</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Stowasser</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>, and <string-name><given-names>R.P.</given-names> <surname>Lifton</surname></string-name>. <year>2018</year>. <article-title>CLCN2 chloride channel mutations in familial hyperaldosteronism type II</article-title>. <source>Nat. Genet</source>. <volume>50</volume>:<fpage>349</fpage>–<lpage>354</lpage>.</mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><string-name><surname>Schrecker</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Korobenko</surname></string-name>, and <string-name><given-names>R.K.</given-names> <surname>Hite</surname></string-name>. <year>2020</year>. <article-title>Cryo-EM structure of the lysosomal chloride-proton exchanger CLC-7 in complex with OSTM1</article-title>. <source>Elife</source>. <volume>9</volume>.</mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><string-name><surname>Sepela</surname>, <given-names>R.J.</given-names></string-name>, and <string-name><given-names>J.T.</given-names> <surname>Sack</surname></string-name>. <year>2018</year>. <article-title>Taming unruly chloride channel inhibitors with rational design</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>. <volume>115</volume>:<fpage>5311</fpage>–<lpage>5313</lpage>.</mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><string-name><surname>Steinmeyer</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Ortland</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1991</year>. <article-title>Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel</article-title>. <source>Nature</source>. <volume>354</volume>:<fpage>301</fpage>–<lpage>304</lpage>.</mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><string-name><surname>Stolting</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Fischer</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>. <year>2014a</year>. <article-title>ClC-1 and ClC-2 form hetero-dimeric channels with novel protopore functions</article-title>. <source>Pflugers Arch</source>. <volume>466</volume>:<fpage>2191</fpage>–<lpage>2204</lpage>.</mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><string-name><surname>Stolting</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Fischer</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>. <year>2014b</year>. <article-title>CLC channel function and dysfunction in health and disease</article-title>. <source>Front Physiol</source>. <volume>5</volume>:<fpage>378</fpage>.</mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><string-name><surname>Stolting</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Teodorescu</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Begemann</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Schubert</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Nabbout</surname></string-name>, <string-name><given-names>M.R.</given-names> <surname>Toliat</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sander</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Nurnberg</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lerche</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Fahlke</surname></string-name>. <year>2013</year>. <article-title>Regulation of ClC-2 gating by intracellular ATP</article-title>. <source>Pflugers Arch</source>. <volume>465</volume>:<fpage>1423</fpage>–<lpage>1437</lpage>.</mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><string-name><surname>Suomivuori</surname>, <given-names>C.M.</given-names></string-name>, <string-name><given-names>N.R.</given-names> <surname>Latorraca</surname></string-name>, <string-name><given-names>L.M.</given-names> <surname>Wingler</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Eismann</surname></string-name>, <string-name><given-names>M.C.</given-names> <surname>King</surname></string-name>, <string-name><given-names>A.L.W.</given-names> <surname>Kleinhenz</surname></string-name>, <string-name><given-names>M.A.</given-names> <surname>Skiba</surname></string-name>, <string-name><given-names>D.P.</given-names> <surname>Staus</surname></string-name>, <string-name><given-names>A.C.</given-names> <surname>Kruse</surname></string-name>, <string-name><given-names>R.J.</given-names> <surname>Lefkowitz</surname></string-name>, and <string-name><given-names>R.O.</given-names> <surname>Dror</surname></string-name>. <year>2020</year>. <article-title>Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor</article-title>. <source>Science</source>. <volume>367</volume>:<fpage>881</fpage>–<lpage>887</lpage>.</mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><string-name><surname>Thiemann</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Grunder</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, and <string-name><given-names>T.J.</given-names> <surname>Jentsch</surname></string-name>. <year>1992</year>. <article-title>A chloride channel widely expressed in epithelial and non-epithelial cells</article-title>. <source>Nature</source>. <volume>356</volume>:<fpage>57</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><string-name><surname>Varela</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>M.I.</given-names> <surname>Niemeyer</surname></string-name>, <string-name><given-names>L.P.</given-names> <surname>Cid</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2002</year>. <article-title>Effect of an N-terminus deletion on voltage-dependent gating of the ClC-2 chloride channel</article-title>. <source>J. Physiol</source>. <volume>544</volume>:<fpage>363</fpage>–<lpage>372</lpage>.</mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Kong</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Yan</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Tian</surname></string-name>, and <string-name><given-names>X.</given-names> <surname>Wang</surname></string-name>. <year>2017</year>. <article-title>Research and progress on ClC2 (Review)</article-title>. <source>Mol Med Rep</source>. <volume>16</volume>:<fpage>11</fpage>–<lpage>22</lpage>.</mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>S.S.</given-names> <surname>Preisler</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Cui</surname></string-name>, <string-name><given-names>J.W.</given-names> <surname>Missel</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Gronberg</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Gotfryd</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Lindahl</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Andersson</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Calloe</surname></string-name>, <string-name><given-names>P.F.</given-names> <surname>Egea</surname></string-name>, <string-name><given-names>D.A.</given-names> <surname>Klaerke</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>, <string-name><given-names>P.A.</given-names> <surname>Pedersen</surname></string-name>, <string-name><given-names>Z.H.</given-names> <surname>Zhou</surname></string-name>, and <string-name><given-names>P.</given-names> <surname>Gourdon</surname></string-name>. <year>2019</year>. <article-title>Structure of the human ClC-1 chloride channel</article-title>. <source>PLoS Biol</source>. <volume>17</volume>:<fpage>e3000218</fpage>.</mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>Z.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Shan</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Xie</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ye</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Pan</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Jiang</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Peng</surname></string-name>, and <string-name><given-names>X.</given-names> <surname>Zhong</surname></string-name>. <year>2023</year>. <article-title>Biallelic CLCN2 mutations cause retinal degeneration by impairing retinal pigment epithelium phagocytosis and chloride channel function</article-title>. <source>Hum. Genet</source>. <volume>142</volume>:<fpage>577</fpage>–<lpage>593</lpage>.</mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><string-name><surname>Yamada</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Krzeminski</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Bozoky</surname></string-name>, <string-name><given-names>J.D.</given-names> <surname>Forman-Kay</surname></string-name>, and <string-name><given-names>K.</given-names> <surname>Strange</surname></string-name>. <year>2016</year>. <article-title>Role of CBS and Bateman Domains in Phosphorylation-Dependent Regulation of a CLC Anion Channel</article-title>. <source>Biophys. J</source>. <volume>111</volume>:<fpage>1876</fpage>–<lpage>1886</lpage>.</mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="journal"><string-name><surname>Yusef</surname>, <given-names>Y.R.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Zuniga</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Catalan</surname></string-name>, <string-name><given-names>M.I.</given-names> <surname>Niemeyer</surname></string-name>, <string-name><given-names>L.P.</given-names> <surname>Cid</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2006</year>. <article-title>Removal of gating in voltage-dependent ClC-2 chloride channel by point mutations affecting the pore and C-terminus CBS-2 domain</article-title>. <source>J. Physiol</source>. <volume>572</volume>:<fpage>173</fpage>–<lpage>181</lpage>.</mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><string-name><surname>Zagotta</surname>, <given-names>W.N.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Hoshi</surname></string-name>, and <string-name><given-names>R.W.</given-names> <surname>Aldrich</surname></string-name>. <year>1990</year>. <article-title>Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB [see comments]</article-title>. <source>Science</source>. <volume>250</volume>:<fpage>568</fpage>–<lpage>571</lpage>.</mixed-citation></ref>
<ref id="c100"><mixed-citation publication-type="journal"><string-name><surname>Zifarelli</surname>, <given-names>G</given-names></string-name>. <year>2022</year>. <article-title>The Role of the Lysosomal Cl(-)/H(+) Antiporter ClC-7 in Osteopetrosis and Neurodegeneration</article-title>. <source>Cells</source>. <volume>11</volume>.</mixed-citation></ref>
<ref id="c101"><mixed-citation publication-type="journal"><string-name><surname>Zifarelli</surname>, <given-names>G.</given-names></string-name>, and <string-name><given-names>M.</given-names> <surname>Pusch</surname></string-name>. <year>2007</year>. <article-title>CLC chloride channels and transporters: a biophysical and physiological perspective</article-title>. <source>Rev. Physiol. Biochem. Pharmacol</source>. <volume>158</volume>:<fpage>23</fpage>–<lpage>76</lpage>.</mixed-citation></ref>
<ref id="c102"><mixed-citation publication-type="journal"><string-name><surname>Zuniga</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>M.I.</given-names> <surname>Niemeyer</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Varela</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Catalan</surname></string-name>, <string-name><given-names>L.P.</given-names> <surname>Cid</surname></string-name>, and <string-name><given-names>F.V.</given-names> <surname>Sepulveda</surname></string-name>. <year>2004</year>. <article-title>The voltage-dependent ClC-2 chloride channel has a dual gating mechanism</article-title>. <source>J. Physiol</source>. <volume>555</volume>:<fpage>671</fpage>–<lpage>682</lpage>.</mixed-citation></ref>
</ref-list>
<sec id="s6">
<fig id="fig2s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2 - figure supplement 1.</label>
<caption><title>Micrograph and 2D classes and structure validation of CLC2-TM.</title>
<p>(<bold>A</bold>) Representative motion-corrected cryo-EM micrograph. (<bold>B</bold>) 2D class averages. (<bold>C</bold>) Gold standard FSC plots calculated in cryoSPARC. (<bold>D</bold>) Local resolution of the cryo-EM map of the CLC2-TM. (<bold>E</bold>) Model validation using Q-scores (<xref ref-type="bibr" rid="c76">Pintilie et al., 2020</xref>) of subunit A (left) and subunit B (right). The black line represents the expected Q-score at respective resolution based on the correlation between Q-scores and map resolution.</p></caption>
<graphic xlink:href="553136v1_figs2-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2 - figure supplement 2.</label>
<caption><title>CryoEM workflow of the CLC2 single-particle cryoEM data processing.</title>
<p>A total of 14,198 movie stacks were collected on a 300 kV Titan Krios cryo-electron microscope. cryoSPRAC was used for 2D classification, and the CLC2-TM density map was obtained after 2D classification. Relion was used for 3D classification and yielded two conformations differing in the CTD: CLC2-CTDsym and CLC2-CTDasym. Resolutions shown refer to the whole protein molecule.</p></caption>
<graphic xlink:href="553136v1_figs2-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2 - figure supplement 3.</label>
<caption><title>Helix map of CLC2-TM.</title>
<p>cryo-EM densities and model of CLC-2 transmembrane helices.</p></caption>
<graphic xlink:href="553136v1_figs2-3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2s4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2 - figure supplement 4.</label>
<caption><title>E<sub>gate</sub> position and Cl<sup>−</sup> binding sites (S<sub>ext</sub> and S<sub>cen</sub>).</title>
<p>(<bold>A</bold>) Comparison between CLC-2 (purple), CLC-1 (light blue), and cmCLC (salmon pink). E<sub>gate</sub> (E205 in CLC-2, E232 in CLC-1, and E210 in cmCLC), Ser<sub>C</sub> (S162 in CLC2, S189 in CLC-1, and S165 in cmCLC) and Tyr<sub>C</sub> (Y553 in CLC-2, Y578 in CLC-1, and Y515 in cmCLC) are shown as sticks. In CLC-2 and cmCLC, S<sub>ext</sub> is occupied by Cl<bold><sup>−</sup></bold>, and S<sub>cen</sub> is occupied by E<sub>gate</sub>. E<sub>gate</sub> is in the “down” position. In CLC-1, S<sub>ext</sub> is occupied by Cl<bold><sup>−</sup></bold>, and S<sub>cen</sub> lacks anion density. E<sub>gate</sub> is in the “out” position, away from the Cl<sup>−</sup>-permeation pathway. (<bold>B</bold>) Overlay view (stereo) of panel <bold>A</bold>. (<bold>C</bold>) Overlay with the CLC-2 E<sub>gate</sub> conformations modeled in PDB ID: 7XJA (<xref ref-type="bibr" rid="c58">Ma et al., 2023</xref>).</p></caption>
<graphic xlink:href="553136v1_figs2-4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3 - figure supplement 1.</label>
<caption><title>Cl<sup>−</sup> pathway in CLC-2 and CLC-1.</title>
<p>(<bold>A</bold>) CLC-2 Cl<sup>−</sup> pathway as shown in <xref rid="fig3" ref-type="fig">Figure 3</xref> but omitting sections with pore radius less than 1Å. E<sub>gate</sub>, occupying the S<sub>cen</sub> site, blocks the canonical Cl<sup>−</sup> pathway. (<bold>B</bold>) same as panel A, for CLC-1 (PDB ID:6coy).</p></caption>
<graphic xlink:href="553136v1_figs3-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3 - figure supplement 2.</label>
<caption><title>Comparison of primary and secondary Cl<sup>−</sup> pathways with transporter Cl<sup>−</sup> and H<sup>+</sup> pathways.</title>
<p>(<bold>A</bold>) The top two panels are repeated from <xref rid="fig3" ref-type="fig">Figure 3A</xref>, indicating the primary (orange) and secondary (yellow) caver-detected pores in CLC-1 and CLC-2. The lower panel shows CLC-ec1 (PDB ID: 1OTS), a representative for the CLC transporters, where caver detects only the primary pore (orange dots as for CLC-1 and CLC-2). (<bold>B</bold>) Detected pore radii show a longer constriction in the CLC-ec1 transporter compared to the CLC-1 and CLC-2 channels. (<bold>C</bold>) Zoomed-in view of the secondary-pore region for CLC-2 (top), CLC-1 (middle) and CLC-ec1 (bottom). The CLC-ec1 panel shows water wires detected in simulations of the QQQ mutant structure (PDB ID: 6V2J) (<xref ref-type="bibr" rid="c13">Chavan et al., 2020</xref>), with oxygen in red dots and hydrogen in white dots.</p></caption>
<graphic xlink:href="553136v1_figs3-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4 - figure supplement 1.</label>
<caption><title>Structure validation of CLC2-CTDsym and CLC2-CTDasym.</title>
<p>(<bold>A</bold>) Gold standard FSC plots calculated in cryoSPARC for CLC2-CTDsym. (<bold>B</bold>) Local resolution of the cryo-EM map of the CLC2-CTDsym. (<bold>C</bold>) Model validation using Q-scores of subunit A (left) and subunit B (right) of CLC2-CTDsym. The black line represents the expected Q-score at respective resolution based on the correlation between Q-scores and map resolution. (<bold>D-F</bold>) the same as (<bold>A-C</bold>) for CLC2-CTDasym.</p></caption>
<graphic xlink:href="553136v1_figs4-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4 - figure supplement 2.</label>
<caption><title>CryoEM density maps for the two CTD-containing CLC-2 conformations, overlaid with structural models.</title>
<p>(<bold>A</bold>) CLC2-CTDsym. (<bold>B</bold>) CLC2-CTDasym. Side view (left) and top view (right) are shown. (<bold>C</bold>) CTD of CLC2-CTDsym shows two CBS domains on each subunit (orange and light orange for subunit A; gray and light gray for subunit B).</p></caption>
<graphic xlink:href="553136v1_figs4-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4 - figure supplement 3.</label>
<caption><title>MD analysis indicates conformational flexibility of the CTD.</title>
<p>(<bold>A</bold>) The CTD is highly mobile relative to the transmembrane domain, and often tilts upward or downward relative to its initial location. In the inset images, two representative frames from simulation are shown (orange) overlaid on the starting structure (black outline). (<bold>B</bold>) The RMSD (root mean square deviation) and RMSF (root mean square fluctuation) of the cytoplasmic domain backbone were calculated after aligning frames on the transmembrane domains. Bars show the mean of five independent simulations, each 2.0 μs in length. Error bars are 68% confidence intervals of the mean.</p></caption>
<graphic xlink:href="553136v1_figs4-3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4 - figure supplement 4.</label>
<caption><title>Comparison of CTD orientation with respect to the TM domain.</title>
<p>(<bold>A</bold>) The CLC-1 structure is shown in light blue. The angle of orientation for the CTDs was calculated using the far end residue of helix T (the second helix of first CBS domain) as the end point of rays and the center of the TM-CTD connecting plane as the vertex of the angle. On the right the CTD is shown in surface representation following rotation as indicated. Panels (<bold>B</bold>) – (<bold>F</bold>) show the CLC homolog indicated, with angles calculated as for CLC-1, and the rotated view of the CTD shown to compare the positioning of the CTDs relative to the membrane domains. The dashed lines indicate the long axes of the CTDs. In each panel, CLC-1 is shown in light blue as a reference for comparison. (<bold>G</bold>) and (<bold>H</bold>) overlays compare the CTD orientations in the CLC-2 structures to that in CLC-7. PDB IDs are shown in the parentheses. PDB IDs for CLC2-CTDsym and CLC2-CTD asym are 8TA4 and 8TA5.</p></caption>
<graphic xlink:href="553136v1_figs4-4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4s5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4 - figure supplement 5.</label>
<caption><title>ATP binding site comparison between CLC-2 and CLC-5.</title>
<p>Top: Structural overlay of CLC2-CTDsym (in orange) and CLC5-CTD (in dark purple) with ATP (pink carbon atoms; CPK coloring on non-carbon atoms. PDB ID: 2J9L). Bottom: Zoomed in stereo view of ATP binding site in CLC5-CTD (dark purple) overlaid with the same region in CLC2-CTDsym (orange). Residue numbers are labeled in dark purple for CLC-5 and orange for CLC-2.</p></caption>
<graphic xlink:href="553136v1_figs4-5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig5s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5 supplement 1.</label>
<caption><title>N-terminal hairpin sequence is conserved in CLC-2, but not other CLCs.</title>
<p>(<bold>A</bold>) Alignment of the N-terminal hairpin sequence (blue boxed) amongst different species. (<bold>B</bold>) Alignment of N-terminal hairpin sequence (blue boxed) amongst other human CLCs.</p></caption>
<graphic xlink:href="553136v1_figs5-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig5s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5 - figure supplement 2.</label>
<caption><title>MD simulations confirm the N-terminal hairpin structure is stable</title>
<p>(<bold>A</bold>) In simulations, the N-terminus (blue) remains stably bound to the intracellular side of the transmembrane domain (orange). In the inset image, frames of the N-terminus taken every 200 ns from a representative simulation are overlaid. (<bold>B</bold>) The root-mean-square deviation (RMSD) and root-mean-square fluctuation (RMSF) of the N-terminus backbone were calculated after aligning frames on the transmembrane domains. Bars show the mean of five independent simulations, each 2.0 μs in length. Error bars are 68% CI (confidence interval of the mean).</p></caption>
<graphic xlink:href="553136v1_figs5-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig5s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5 - figure supplement 3.</label>
<caption><p>The N-terminal hairpin blocks the primary Cl<sup>−</sup> pore in CLC-2. (<bold>A</bold>) <italic>Left:</italic> Side view of CLC2-TM showing the caver-detected pore (primary in orange and secondary in yellow). <italic>Right:</italic> View of the primary pore from the intracellular side. (<bold>B</bold>) The N-terminal hairpin (blue) overlaid with CLC2-TM as shown in panel <bold>A</bold>.</p></caption>
<graphic xlink:href="553136v1_figs5-3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig5s4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5 - figure supplement 4.</label>
<caption><title>Mapping mutant data onto the cryoEM structure.</title>
<p>(<bold>A</bold>) Left: same as <xref rid="fig5" ref-type="fig">Figure 5C</xref>, showing hairpin interactions. Right: Rotated view highlighting ball “receptor” residues identified by <xref ref-type="bibr" rid="c49">Jordt and Jentsch, 1997</xref>. (<bold>B</bold>) Residues mutated in human Aldosteronism (<xref ref-type="bibr" rid="c32">Fernandes-Rosa et al., 2018</xref>, <xref ref-type="bibr" rid="c84">Scholl et al., 2018</xref>) and Leukoencephalopathy (Hector <xref ref-type="bibr" rid="c34">Gaitan-Penas., 2017</xref>) are shown on CLC2-CTDsym in magenta and green, respectively.</p></caption>
<graphic xlink:href="553136v1_figs5-4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6 - figure supplement 1.</label>
<caption><p>Data traces from the CLC-2 run-up experiments summarized in <xref rid="fig6" ref-type="fig">Figure 6G</xref>. For Delta-N, separate scale bars indicate the currents for the top six and bottom 10 traces. AK-42 leak currents, not subtracted in these raw data traces, are summarized in Figure 6 - source data 1.</p></caption>
<graphic xlink:href="553136v1_figs6-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6 - figure supplement 2.</label>
<caption><title>CLC-2 current rectification.</title>
<p>(<bold>A</bold>) Example traces from two experiments on WT CLC-2. Current values at end of the −100-mV test pulses and in the steady-state portion of the +80-mV tail pulse (following the +20-mV test pulse) are indicated. Robust AK-42 inhibition of the current at +80 mV indicates that CLC-2 is passing current at positive voltages. (<bold>B</bold>) Rectification ratios. Rectification was quantified by taking the ratio (absolute value) of the leak-subtracted currents at −100 mV and +80 mV. For WT initial currents, the low currents at +80 mV make this quantification challenging: for 5 out of 8 experiments on WT CLC-2, the AK-42 current at +80 mV was greater than the initial WT current at +80 mV, likely due to an increase in leak over the course of the experiment (∼15 minutes of voltage pulsing). Therefore, the rectification calculated for the WT initial currents (99 ± 34, SEM n=3) has substantial uncertainty. That said, such high rectification is consistent with reports of CLC-2 rectification throughout the literature (<xref ref-type="bibr" rid="c73">Park et al., 1998</xref>; <xref ref-type="bibr" rid="c7">Arreola et al., 2002</xref>; <xref ref-type="bibr" rid="c47">Jentsch and Pusch, 2018</xref>). On the other hand, Delta-N currents display only mild rectification, which is straightforward to quantify given the high signal:noise (high AK-42-sensitive current relative to background), and which does not change in response to voltage pulsing. For “WT-final”, the rectification ratio similarly can be accurately quantified. Thus, while the high uncertainty and variance in estimating WT initial rectification precludes quantitative statistical comparisons, these data strongly suggest that WT CLC-2 current rectification decreases in parallel to current run-up. Data for all experiments are summarized in <bold>Figure 6 - source data 1</bold>.</p></caption>
<graphic xlink:href="553136v1_figs6-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 1.</label>
<caption><title>cryoEM workflow of the CLC2-TM-AK42 single-particle cryo-EM data processing.</title>
<p>A total of 14,300 movie stacks were collected on a 300 kV Titan Krios cryo-electron microscope. cryoSPRAC was used for 2D classification and CLC2-TM-AK42 density map was obtained after 2D classification. Relion was used for 3D classification.</p></caption>
<graphic xlink:href="553136v1_figs7-1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 2.</label>
<caption><title>Micrograph and 2D classes and structure validation of CLC2-AK42.</title>
<p>(A) Representative motion-corrected cryo-EM micrograph. (B) 2D class averages. (C) Gold standard FSC plots calculated in cryoSPARC for CLC2-TM-AK42 (left) and CLC2-AK42-CTD-only (right). (D) Local resolution of the cryo-EM map for CLC2-TM-AK42 (left) and CLC2-AK42-CTD-only (right)</p></caption>
<graphic xlink:href="553136v1_figs7-2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 3.</label>
<caption><title>Model validation using Q-scores.</title>
<p>(<bold>A</bold>) Q-scores of CLC2-TM-AK42 for subunit A (left) and subunit B (right). (<bold>B</bold>) Q-scores of CLC2-AK42-CTD-only for subunit A (left) and subunit B (right). The black line represents the expected Q-score at respective resolution based on the correlation between Q-scores and map resolution.</p></caption>
<graphic xlink:href="553136v1_figs7-3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 4.</label>
<caption><title>cryoEM map and structure of CLC2-AK42.</title>
<p>(<bold>A</bold>) cryoEM model of CLC2-TM-AK42 with docked CTD. The transmembrane region is shown in hot pink and gray. The CTD is shown in green and gray. AK-42 is shown in yellow and highlighted by yellow circles. Chloride ions are shown in green. (<bold>B</bold>) cryoEM model overlay with density map of CLC2-AK42.</p></caption>
<graphic xlink:href="553136v1_figs7-4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 5.</label>
<caption><title>Helix map of CLC2-TM-AK42.</title>
<p>cryo-EM densities and model of CLC2-AK42 transmembrane helices.</p></caption>
<graphic xlink:href="553136v1_figs7-5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 6.</label>
<caption><title>Density overlay at key Cl<sup>−</sup>-pathway residues.</title>
<p>Zoomed-in view highlighting residues S162, E205, Y553, and the bound chloride ion, with cryoEM density overlay.</p></caption>
<graphic xlink:href="553136v1_figs7-6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 7.</label>
<caption><title>AK-42 binding site comparison between CLC2-TM and CLC2-TM-AK42.</title>
<p>Top: Stereo view of structural overlay at the AK-42 binding site. Hydrogen bonds between AK-42 and residues K204,S392,K394 are indicated by blue dashed lines. Bottom: A view highlighting the movement of residue M460 to make space for AK-42.</p></caption>
<graphic xlink:href="553136v1_figs7-7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 8.</label>
<caption><title>Structural comparison of CLC2-TM and CLC2-TM-AK42.</title>
<p>Difference distance matrices comparing Cɑ residues on TM helices between CLC2-TM and CLC2-TM-AK42 in subunits A (<bold>A</bold>) or B (<bold>B</bold>). Residues in loops connecting helices, where there is low confidence in the model building (Q score lower than the expected Q score of 0.65), were omitted from the matrices.</p></caption>
<graphic xlink:href="553136v1_figs7-8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig7s9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7 - figure supplement 9</label>
<caption><title>AK-42 binding site comparison between CLC-2 and CLC-1.</title>
<p>(<bold>A</bold>) Top: Stereo view of the AK-42 binding site in CLC2-TM-AK42 (hot pink) overlaid with the same region in CLC-1 (blue, PDB:6coy). Residue numbers correspond to those of CLC-2. The five residues that differ between CLC-2 and CLC-1 are: I112 (S139), S392 (M419), Q393 (P420), K394 (R421), and L397 (I424). Bottom: Rotated (stereo) view of AK-42 binding site to compare residues S392, Q393 and K394 in CLC-2 versus M419, P420 and R421 in CLC-1. These three were calculated to contribute most significantly to the AK-42 binding energy (Ma, 2023). (<bold>B</bold>) Residues in CLC-1 predicted to clash with AK-42. AK-42 is shown in yellow sticks and white surface. F252 and M460 in CLC-2 correspond to F279 and M485 in CLC-1.</p></caption>
<graphic xlink:href="553136v1_figs7-9.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90648.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Stockbridge</surname>
<given-names>Randy B</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Michigan</institution>
</institution-wrap>
<city>Ann Arbor</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Fundamental</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>fundamental</bold> study examines the human voltage-gated chloride channel CLC-2. A <bold>compelling</bold> approach that combines cryo-EM, electrophysiology, and computational analysis provides <bold>convincing</bold> support for a &quot;ball and chain&quot; mechanism of inactivation. This and other findings regarding the gating and inhibition mechanisms of the channel are fundamentally interesting to ion channel physiologists.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90648.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>This manuscript deftly combines cryo-EM and electrophysiology to investigate the gating mechanisms of human CLC-2. Although another structure of CLC-2 was recently reported, this is the first structure to report density for the absolutely critical gating glutamate, and - an even more exciting result - the first structure to identify the N-terminal gating peptide that is the heart of this manuscript. There has been previous controversy over such a gating peptide in CLC-2, but the combined structural/functional approach appears to establish a role for this peptide in gating and sets up exciting future experiments to understand why its effects might change under different physiological scenarios. The experiments reported here are thoughtful and well-controlled and the data presentation is excellent. For the electrophysiology experiments, the use of inhibitor AK-42 (developed by the current senior author's lab) to establish a zero current level is a welcome advance and should become standard for electrophysiological studies of CLC-2.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90648.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>This paper makes important and novel advances that significantly enhance our understanding of the ClC-2 channel. The EM data are of high quality, and the most important argument, concerning the role of the N-terminus of the protein as an occluding inactivation gate, is very well supported by structural, computational, and functional data (some of which is previously published). The proposal that the &quot;run up&quot; observed in patch clamp experiments represents relief of inactivation is interesting and compelling. The model predicts that mutations at the hairpin binding site should influence this &quot;run up&quot;, which should be tested in the near future. Finally, the confirmation of the AK-42 binding site further solidifies evidence that this is a pore-blocking compound; the authors' argument about determinants of specificity is convincing.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90648.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary</p>
<p>
CLC-2 channels play an important role in cellular homeostasis and electrical excitability, and dysfunctions are associated with aldosteronism and leukodystrophy. Structural insights into the functioning of CLC-2 are just emerging. CLC-2 channels are distinct among the members of the CLC family in that they are activated by hyperpolarization. Earlier studies have implicated channel regulation by a &quot;ball-and-chain&quot; type of channel block mechanism which underlies its strong rectification and use-dependent &quot;run-up&quot; properties. Structural insights into these mechanisms are currently lacking. In this manuscript, Xu et al present CryoEM structures of CLC-2 in the apo and inhibitor-bound conformations in the 2.5-2.7 A resolution range. Several novel structural features are presented that lend support to the &quot;ball-and chain&quot; model, identify an interesting role for the c-terminal domain in gating, and establish the interaction pocket for AK-42. Electrophysiology and simulations nicely support the structural work. Overall, an elegant study, with high-quality data, and a well-presented manuscript.</p>
<p>Strengths</p>
<p>
1. The cryoEM data presented reveals that the channel is in a closed conformation at depolarizing potential (0 mv). Structures for the closed state of CLCs were not previously available. A strong density for Glu205, which constitutes the Egate, allows for an unambiguous assignment of its position at the Scen Cl-binding site, thereby establishing the basis for the block in the closed channel.</p>
<p>
2. The apo state particles were sorted into two classes that differ in the conformation of the CTD. A previously unobserved rearrangement of the CBS region in the CTD is reported wherein the CTD is positioned closer to the TM region in one of the subunits, breaking the C2 symmetry. The data implicates a role for the conformational flexibility of CTD in gating.</p>
<p>
3. The most interesting finding of this work is, perhaps, the presence of an additional density, corresponding to a hairpin-like structure, that is seen only at the subunit where the CTD is positioned away from the TMD. The authors propose that the additional density corresponds to a 13 aa stretch in the N-terminal region. The position of the hairpin at the intracellular mouth of the CL-permeation pathway is likely to impede ion conduction, by a mechanism analogous to the &quot;ball-and-chain&quot; proposed in other voltage-gated channels.</p>
<p>
4. The structure of CLC-2 in complex with a selective inhibitor AK-42 is in a conformation very similar to that of the apo state, with a clear additional density for the AK-42 molecule. Binding site interaction provides insights into AK-42 selectivity for CLC-2 vs CLC-1.</p>
<p>Weaknesses</p>
<p>
Although the conformation-dependent placement of the hairpin loop is convincing based on the density, the sequence assigned to this region is not conclusive.</p>
</body>
</sub-article>
</article>